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HEMOPROTEIN-MEDIATED ACTIVATION OF NITROALKANES
LING LI
ABSTRACT

Chemicals and drugs are known to be metabolized mostly by Cytochrome P450
xenobiotic metabolizing enzymes. However, the detailed mechanism of nitro-compounds
metabolism is still unclear. The activation of nitro-xenobiotics by heme-P450 enzymes is
a potential explanation for the origin of nitro-compound carcinogenesis. Investigating the
interaction of simple nitro-compounds with redox activity of heme enzymes is therefore
critical to explore the mechanism and products of activation.
In this study, multiple analytical methods and instrumentations are employed and
graphic and simulation software such as Origin® and Digisim® are utilized to
quantitatively derive parameters from experimental raw data. This study shows that
myoglobin, iron-protoporphyrin-IX (hemin), and the oxygenase domain of inducible
nitric oxide synthase (iNOSoxy) act as efficient electrocatalysts for nitroalkane
reductions in the surfactant films on pyrolytic graphite electrodes.
In the study using myoglobin as a model electrocatalyst for the electroreduction of
nitromethane, the catalytic activity is evaluated using Michaelis-Menten kinetics. The
apparent Km and the turnover number kcat are derived from non-linear regression of
Michaelis-Menten plot using Origin software. The reductive products of catalytic
electroreduction of nitromethane are identified by a mass spectrometric method. We also
identified a ferrous heme-nitrosomethane as the intermediate in the catalytic process
using

UV-Vis

spectroscopy

and

electrochemical

iv

techniques.

We

show

the

electrochemical signature of a nitrosoalkane-heme complex that is possibly involved in
the mechanism of activation of aliphatic nitro-compounds xenobiotics. A possible hememediated electroreductive pathway is proposed.
In this work, we also explored the comparative study of the electroreduction of
nitromethane using myoglobin, hemin, and iNOSoxy as the electrocatalysts. We
discussed the role of the protein shell in the activation process. We also studied four
different aliphatic nitroalkanes as substrates to study their electro activation using hemin
and iNOSoxy as electrocatalysts, and used a mass spectrometric method to identify the
reduction products. By comparing the catalysis of each nitroalkane substrate and by
varying experimental conditions such as scan rate of cyclic voltametry, substrate
concentration, and pH, we discussed the effects caused by the physical and chemical
properties of the substrates on their electrocatalytic reductions.

v
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GENERAL INTRODUCTION

Due to their widespread use, the human body is frequently exposed to nitrocompounds. Nitroalkanes are recognized as carcinogens1, 2, genotoxicant,2,

3

and are

suspected as cardiovascular toxins and neurotoxins.4-6 The detailed mechanism of
nitroalkane-induced carcinogenesis is still unclear. It is believed that nitro-compound
activation may take place in the liver, catalyzed by xenobiotic enzymes under anaerobic
conditions through catalytic electron transfer.7, 8 Research has shown that cytochrome
P450 participates in the reductive metabolism of nitro-compounds.9 It also has been
reported that 2-nitropropane reductive metabolite, N-isopropylhydroxylamine (IPHA),
frequently causes DNA damage at thymine.2 The formation of 8-hydroxydeoxyguanosine
(8-OHdG) induced by IPHA is speculated to be involved in oxidative stress-related
carcinogenesis.10 To better comprehend the carcinogenesis of nitro-compounds, it is
important to understand the fundamental reductive pathways catalyzed by heme-base
proteins and enzymes.
Chemicals (including drugs) involve two-phase reactions in the metabolism. Phase I
reactions are nonsynthetic reactions, including reduction, oxidation, and hydrolysis.
Phase II reactions are known as conjugation reactions, and usually involve the
interactions of the metabolites from phase I. This process usually detoxicates the
chemicals. These reactions are catalyzed by a family of enzymes called xenobiotic
metabolizing Cytochrome P450s. The metabolizing process will result in toxication or
detoxication, also called activation and deactivation. The mechanisms of cytochrome
P450 catalysis and inhibition have been the subject of intense studies in recent years. 11-14
Carcinogen and mutagen activations which occur in phase I are closely related to the
1

activity of Cytochrome P450s. Therefore, Cytochrome P450s became vital enzymes for
the study of the mechanism of formation of carcinogenic metabolites.
Traditional methods of enzyme activity study include assays on initial rate, progress
curve and transient kinetics through varying techniques such as spectrophotometric
methods, light scattering methods, fluorometric methods, chemiluminescent methods,
calorimetric methods, chromatographic methods, and radiometric methods. These
methods can resolve enzyme mechanisms in concentration and time domain by
measuring concentration change of substrate or product versus time, but little information
can be obtained on the mechanism of catalytic reaction at the molecular level.
Most commonly used analytical techniques in recent investigations of P450 enzymes
and their activation of xenobiotic compounds or their metabolites are HPLC, UV-Vis,
Mass Spectrometry, and Electrochemical methods. Electrochemical methods show the
advantages of being quantitative, sensitive and relatively uncomplicated.
Since more than 30% of enzymes are oxidoreductases including P450 heme enzymes,
their activities involve electron transfer coupled with substrate transformation at the
catalytic site that can be monitored electrochemically. This dynamic voltammetric
approach obtains not only the kinetic information of enzymatic reactivity, but also the
electrochemical potential, which defines the oxidation states and the rate of catalytic
reaction.
The voltammetric electrochemical method on biomolecules such as proteins showed
its potential first in the late 1970’s when the direct (unmediated) voltammetry of
cytochromes was obtained at solid electrodes.15 This approach was enhanced when
enzymes or other molecules of interest are attached or absorbed on the electrode surface.
2

The techniques of immobilization includes covalent attachment, self assembled
monolayers (SAM), and bilayer thin film methods or layer-by-layer assembly. The
commonly used materials used for these applications as solid electrodes are platinum,
gold, silver, or even indium doped tin oxide transparent electrodes.
In our study, we use mostly the lipid bilayer thin film method. The catalysts or
enzymes under investigation are embedded in a biomembrane-like surfactant bilayer
structure on the surface of pyrolytic graphite electrode. The electrochemical studies of the
enzymatic activity are combined with other analytical chemical techniques, such as
spectrophotometric methods and mass spectrometric methods, in effort to understand the
underlying mechanism of enzymatic or heme-based catalytic nitroalkane electroreduction.

3

CHAPTER I
CURRENT METHODS OF INVESTIGATING THE METABOLISMS OF
NITROCOMPOUNDS

1.1 Introduction

Nitroalkanes are widely used as solvents, chemical intermediates or fuel in racing
cars or rockets. Large amounts of nitroalkanes are released into the environment and
result in environmental contamination. Chronic intake of these compounds may cause
neuropathy,4 DNA damage,2, 3 and cancer.16, 17
As other xenobiotics, the metabolism of nitroalkanes is catalyzed by a superfamily of
enzymes called Cytochrome P450s (CYPs). Human CYPs are mostly membraneassociated enzymes, located either in the endoplasmic reticulum or in the inner
membrane of mitochondria of cells, and some CYPs exit in cytosol as well. CYPs are in
charge of metabolizing thousands of exogenous and endogenous compounds. Most CYPs
can metabolize multiple substrates, and many can catalyze multiple reactions, which
enable them to catalyze the transformation and degradation a large variety of molecules.

4

Cytochromes are proteins that carry a heme protoporphyrin IX group as their
prosthetic group, Figure 1.1. The heme group is a highly conjugated ring with an iron
atom in the center. The oxidation states of iron readily interconverts between +2 and +3
through electron transfer. It can perform as either an electron source or an electron sink.
This characteristic makes it capable to catalyze either oxidations or reductions.
Cytochromes P450 serve crucial functions in humans. The subfamily that act as
xenobiotic-metabolizing enzymes is a prime target in pharmacology and drug
development.18. The name P450 comes from its characteristic Soret peak at 450 nm of the
reduced carbon monoxide-bound complex19, 20. P450 enzymes catalyze the activation of a
variety of xenobiotics including almost all drugs and chemicals. For example, P450
enzymes metabolize organic nitrates,

21, 22

lauric acid and ethanol.

23

Cytochrome P450

belongs to a multi-gene family; so far more than 6,400 distinct Cytochrome P450
sequences are known from all variants of life, including mammals, plants, and even
bacteria. There are 57 genes and 59 pseudogenes recognized so far coded for different
Cytochrome P450s in the human genome.

5

Figure 1.1 Crystal Structure of human cytochrome P450 46A1
Image from PDB 2Q9G

6

There is a structural diversity among Cytochrome P450s. Nonetheless, they share
many common features: 1) Cytochrome P450s have a heme group as the active site. 2)
The iron in the heme is coordinated to a cysteine thiolate ligand at the proximal site. This
cysteine and many other peptides in the enzyme are highly conserved over all known
Cytochrome P450s. 3) The catalytic function of cytochrome P450 needs other partner
proteins such as Cytochrome P450 reductase or ferredoxins to donate and shuttle
reducing equivalents (electrons) to the heme Fe(III) center.
The mechanisms of cytochrome P450 catalysis and inhibition have been the subject
of intense studies in recent years.

11-14

Carcinogen and mutagen activations which occur

in phase I are closely related to the activity of Cytochrome P450s. Therefore,
Cytochrome P450s became vital enzymes for the study of the mechanism of formation of
carcinogenic metabolites.
The general mechanism of the cytochrome P450 aerobic catalytic cycle is well
known (Scheme 1.1).

24

It involves heme activation (Fe3+ reduces to Fe2+), oxygen

binding and activation, and then hydroxylation of the substrate.

7
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O
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Scheme 1.1 Mechanism of Cytochrome P450 aerobic catalysis24

8

However, not all xenobiotics take the oxidative metabolic pathway. Some nitrocompounds can be reductively activated by Cytochrome P450s.25 Nitroalkanes can either
be reduced or oxidized by different enzymes. They could be oxidized by P450 enzymes
under aerobic conditions initiated by electron transfer, and oxygen activation 7. They
could also be reduced by Cytochrome P450s under anaerobic conditions through catalytic
electron transfer. 7-9 The primary product of nitroalkane reduction is alkyl hydroxylamine
26

. Fitzpatrick’s group reported their work on a FAD-containing enzyme called

nitroalkane oxidase from fungus, and stated that the oxidation products of nitroalkanes
are aldehydes or ketones with nitrite and hydrogen peroxide as side products 27.
Cytochrome P450s are responsible for the metabolism of almost all kinds of
chemicals including drugs. The activation of drugs by P450s can either lead to non-toxic
metabolites or cytotoxicants, genotoxicants, and carcinogens; hence, CYPs are key
enzymes for studying the metabolism and potential toxicity of drugs. A number of
investigations have been carried out to study the effects of nitro-compounds on animal
models or human samples, and there are also reports of cases showing health problems
caused by the exposure to these chemicals. The techniques that have been commonly
used in the studies are the following including spectroscopic methods such as UV-Vis
spectroscopy, infrared spectroscopy, high performance liquid chromatography (HPLC)
coupled UV-Vis or mass spectroscopy (MS), biological techniques such as gel
electrophoresis, comet assay (single cell electrophoresis), Ames mutagenicity test, and
electrochemical methods which are primarily used in our study.
UV-Vis spectroscopy has been commonly used to determine the concentration of
protein samples, quantitatively measure the change of the reactive species, and monitor

9

the formation of new species. Because of its capability, this technique is constantly
applied to the studies of cytochrome P450s catalyzed nitro-compound metabolism.
H.G. Jonen used UV-Vis spectroscopic method to study the nitrofurantoin
metabolism in rat liver under aerobic and anaerobic conditions.28, 29 His results showed
that nitrofurantoin can be rapidly eliminated under anaerobic condition through a
reductive metabolism. Under aerobic condition, the hepatic clearance of this chemical is
slow. 4-hydroxylation of nitrofurantoin is catalyzed by 3-methylcholanthrene-inducible
cytochrome P450.
Mansuy’s group studied the interaction between hemoproteins including P450
enzyme and nitroalkanes and their metabolites under reducing conditions, and found out
that nitroalkanes and hemoproteins form stable ferrous heme nitrosoalkane complexes
under reducing condition using UV-Vis spectroscopic methods30,

31

. Also N-

hydroxylamines can react with Cytochrome P450 under oxidative condition to form the
same type of complexes.32
Christopher Kohl et al reported on the toxicity of the genotoxicant and
hepacarcinogen, 2-nitropropane.33 The results showed that the nitro-aci tautomerism of 2nitropropane catalyzed by rodent or human liver cytosol might be the reason for its
toxicity. The study of 1-nitropyrene activation catalyzed by Human Hepatoblastoma Cell
Line was also reported by Kimberley J. Silvers et al.

34

Their HPLC results showed that

only nitroreduction pathway of 1-nitropyrene by HepG2 could form the DNA adduct, N(2'-deoxyguanosin-8-yl)-l-aminopyrene (dG-CS-AP), and the cytochrome P450-mediated
C-oxidative pathways are detoxification pathways.
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In a recent study of the hepatoxicity of an anti-tumor prodrug 5-(Aziridin-1-yl)-2,4dinitrobenzamide (CB 1954), HPLC coupled to mass spectrometry showed that the major
metabolite, 4-hydroxylamine was formed,35 a potent DNA cross-linking cytotoxin. 2hydroxylamine and 2-amine metabolites were also detected and both of them exhibited
high cytotoxicity. Another study reported on the metabolism of a nitro-containing drug,
N1-phenyl-3,5-dinitro-N4,N4-di-n-butylsulfanilamide (GB-II-150), and showed that the
drug underwent nitroreduction when administered orally. 36
Comet assay is useful to study the genotoxicant by monitoring the DNA damage. An
investigation of 2-nitroproapne-induced DNA damage using animal model by Xin-Sheng
Deng et al37 utilized this method and found out that DNA damage happened in bone
marrow cells thus indicated that 2-ntiropropane could be leukemogenic.
Ames test was used in an investigation carried out by Peter P. Fu et al on the
mutagenesis of nitrobenzo[a]pyrenes (NBaPs).38 The results indicate that isomeric NBaPs
are activated to DNA adducts and mutagenic derivatives by nitroreduction, ringoxidation, or by a combination of these two pathways. Another report using the same
approach to study the mutagenicity of various nitrocompound was conducted by S. G.
Salamanca-Pinzon et al.39 The results illustrated that the mutagenicity of the
nitrocompound metabolites related to nitroreductase proficiency. All nitrocompound
showed more mutagenic after metabolic activation by nitroreductase.
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1.2 Electrochemical methods
The metabolic mechanisms of chemicals catalyzed by cytochrome P450 (CYP)
enzymes involve electron transfer. In biological systems, enzymes such as CYPs have to
use electron donors such as NADPH or NADH to perform their enzymatic activity, and
they are affected by electron transfer mediators such as flavin nucleotides. The advantage
of direct electrochemical methods are that if enzymes such as CYP can be connected to a
solid electrode surfaces by a bridge, and the active site of CYP, a heme group, can
exchange electrons with the underlying electrode, there is no need to have the electron
donors or mediators in the system. We can thus study the enzymatic reactions by
providing electrons directly from the electrode.
The current response on the electrode is directly related to the rate of the reaction and
the amount substrate being processed. Hence it is a quantitative method. When using
dynamic voltammetric technique, electrode potential can reflect thermodynamic
information of the enzyme as well as enzymatic kinetics. High sensitivity is the nature of
electrochemical method; therefore the amount of enzyme sample can be very small.
There are numbers of electrochemical techniques available. Because of the
advantages, electrochemical techniques of studing metalloeproteins especailly CYP heme
enzymes have drawn more and more attention in the last couple of decads. In the
appendix we describe the common methods that we used throughout this work.
Cyclic voltammetry (CV) is probably the most versatile electrochemical technique for
the mechanistic study of redox active systems. Direct electrochemistry of P450 enzyme
was reported in the literature that have protein shows typically a reversible FeIII/FeII
redox couple of the prosthetic heme group.40-43
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1.3 Protein immobilization methods
Before the development of biomolecule immobilization methodology, the
electrochemical studies of proteins or enzymes were carried out in solution and the signal
obtained directly at the working electrode was facilitated by small mediators. This
approach not only requires large amount of enzyme or proteins, but the signal is also very
weak. The protein immobilization method confines the protein on the surface of working
electrodes instead of in solution. This approach not only saves lot of protein sample, but
also enhanced the electrochemical current signal. Since direct (non-mediated) electron
transfer

through

metalloprotein

was

achieved,

the

electrochemical

study

of

metalloproteins began to attract the interest of investigators and became more and more
popular.
The techniques of immobilizing native proteins on working electrodes are critical in
the research and various methods of immobilization are developed for different
applications.
1.3.1 Adsorption
Proteins such as Cytochrome P450s can be directly deposited on the metal or
graphite electrode. Purified CYP solution can be spread on a basal plane pyrolytic
graphite surface,

44

and the film is formed simply by evaporating water naturely. Protein

or peptide modification can also be done electrochemically by cycling a gold electrode at
reducing potentials in the peptide solution as described by J. Kazlauskaite et al.45
Besides direct adsorption, co-adsorbates such as polyamines,46 neomycin47-49, and
polymyxin50-55 have been used for protein immobilization. These polyamines can bind to
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negatively charged parts of protein under neutral pH and form salt bridges between
protein and electrode surface.
Other adsorption methods involves nano-particles56 such as titanate nanotubes,57
carbon nanotubes,58-70, gold nanoparticles,71, 72 and silver nanoparticles.73
1.3.2 Hydrogel or clay entrapment
The electron transfer between the electrode and protein is usually low for a proteinmodified electrode by absorption. Therefore application of substances that facilitates
electron transfer may enhance the intensity of the signal and the stability of the protein
film. There are a numbers of choices of film-forming materials such as colloid size clay,74,
75

hexagonal mesoporous silica (HMS),76 polyacrylamide (PAM) hydrogel films,77, 78 and

carboxymethyl cellulose films,79 to cite a few.
1.3.3 Lipid bilayer thin films
Some amphiphilic compounds (surfactants) such as didodecyl dimethyl ammonium
bromide (DDAB) can form a water-insoluble bilayered film structure that resembles biomembranes on solid electrode surfaces, Figure 1.2. Both hydrophilic and hydrophobic
proteins or other molecules can be embedded into these surfactant thin films. This
method of protein immobilization promotes the electron transfer between the protein and
the electrode. Research had shown that the film is fairly stable in aqueous environment
and the proteins could maintain their native structure in the lipid thin film.80-82 This
method is suitable for applications such as biosensors and bioreactors, and also widely
used in the electrochemical investigations of catalytic mechanisms of enzymes and other
proteins.80, 81, 83-86
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(a)
(b)
(c)

Figure 1.2 Protein immobilized in bio-membrane like lipid film on pyrolytic graphite
(PG) electrode. (a) Lipid molecule (b) Protein moleclue (c) Pyrolytic graphite (PG)
electrode
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1.3.4 Covalent attachment
Biomolecules such as proteins can form covalent bonds with specific chemical
groups on the electrode surface. This usually involves a step called functionalization of
the electrode surface. The desired chemical group(s) is covalently attached to the
electrode surface usually through defined chemical reactions.
Functionalized alkyl thiols can be spontaneously adsorbed onto Au, Pt, and Ag
surface to generate self-assembled monolayers (SAM) with the functional groups
pointing away from the electrode so that it can engage the protein molecules, Figure 1.3.
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Figure 1.3 Immobilization via covalent attachment of proteins
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1.3.5 Layer-by-layer polyion protein adsorption
Electrostatic coupling can be used to deposit charged compounds onto a charged
electrode surface. Layer-by-layer (LBL) deposition is a technique of thin film fabrication.
The method consists of applying oppositely charged polyions respectively with washing
step in between. Just like the name indicates, the resulting film has alternative layers of
negatively charged and positively charged polyions. The number of layer and the
thickness of the film can be well controlled, Figure 1.4. Proteins can bear different
surface charge at different pHs. Therefore this method is used for protein immobilization.
Some multi-charged matrices such as poly(diallyl dimethyl ammonium chloride) (PDDA)
can be used to couple with negatively charged polyions or proteins to form proteincontaining LBL films.
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ELECTRODE

Figure 1.4 Layer-by-layer polyion adsorption
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1.4 The approach we took in our study
The electrochemical technique using surface confined metalloprotein especially
enzymes, may not only apply to substrate-specific biosensors and bioreactors, but can
also be used commonly to study enzymatic activity of metalloenzymes. Since the
majority of cytochrome P450 enzymes are located in hydrophobic environments such as
the reticulum of cells or cell membranes, the study of such type of enzymes needs to
mimic the physiological environments. In this work, we select well-known lipid thin film
immobilization methods to retain our enzymes on the basal plane pyrolytic graphite
working electrode surface. The lipid bilayer structure provides a biomembrane-like
environment in which the protein molecule is embedded. We use electrochemical
techniques as the major tools to characterize the redox activity of the heme group as well
as electro activation of nitroalkane substrates.
In addition to electrochemistry, UV-Vis spectroscopy is routinely used to monitor the
concentration and integrity of hemoproteins. It is also employed to characterize possible
reaction intermediates of heme-mediated catalytic nitroalkane electroreduction.
Final products of electroreductions mediated by immobilized hemoproteins, as well as
their distribution are needed to shed light on the complex activation pathways, and to
identify the plausible mechanism. To analyze the final electroreduction products, we used
bulk electrolysis (i.e. exhaustive reduction at the potential of the catalytic wave on the
heme or (protein)-modified electrode) and analyze the products at different times using
mass spectrometry (MS). The setup that allows for bulk electrolysis and analysis of
products been developed in the past87-90. The system is adapted to this work.
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CHAPTER II
STUDY OF MYOGLOBIN-MEDIATED NITROMETHANE ELECTROREDUCTION AND THE CATALYTIC REACTION MECHANISM

2.1 Introduction
Nitromethane is the simplest aliphatic nitroalkane. It is recognized as a carcinogen,
and is suspected to be a cardiovascular toxin and neurotoxin.1,

2

Nitromethane

transformation in human body is believed to be catalyzed by P450-type xenobiotic
enzymes under anaerobic conditions through catalytic electron transfer.3, 4
Nitromethane is electroactive and can be electroreduced to methyl hydroxylamine at
electrode surface. The process can be simplified as in Equation 1. This electrochemical
reaction consists of 4 electrons and 4 protons uptake in addition to a break of N-O bond
and involves a complex mechanism.5
−

e
CH 3 NO2 + 4 H + ⎯4⎯→
CH 3 NHOH + H 2 O

(1)

The active sites of cytochrome P450s (CYPs) are heme groups. Chemicals and drugs
transformations are catalyzed by the heme groups in P450s. Electrons in CYP-catalyzed
chemical metabolism come from cytochrome P450 reductases involves a subfamily of
33

flavoproteins designed to provide electrons to CYPs. Electrochemical study has the
advantage that proteins can get electrons directly from the electrode, hence the electron
provider CPR and the cofactor NADPH are not required.
Although there are large varieties of CYPs, the active site of the enzyme is highly
conservative. The iron in the heme group is tethered through a thiol ligand from a
cysteine residue, this cysteine and some other amino acid residues around it are also
highly conserved. We chose a simple hemoprotein (myoglobin) to start our study on the
interaction between nitroalkane with heme group. Myoglobin is easily available and had
been electrochemically studied extensively.6-15 Previously published work in this lab has
shown that myoglobin is an efficient catalyst in electroreduction of nitromethane.16
Myoglobin is a primary oxygen-carrying protein in muscle tissues, Figure 2.1. The
crystal structure of myoglobin17 showed that the NЄ atom of the proximal histidine
residue (His93 in horse heart myoglobin) acts as the fifth coordination of the iron atom of
the porphyrin ring, and leave only the distal (or trans-axial) side of the porphyrin plane
accessible to ligands such as oxygen. There is another histidine residue (His64 in horse
heart myoglobin) at the distal side which helps stabilize the binding of the ligand through
hydrogen bonding.
Some electrochemical studies of surface confined myoglobin focused on the
electrochemical characteristics of myoglobin,8,

15

and others also focused on the

myoglobin catalyzed electroreductions.6, 11, 18, 19 In this work, we study the myoglobinmediated nitromethane reduction.
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Figure 2.1 Structure of nitromethane modified horse heart myoglobin
Image from: PDB 2NSR
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Traditionally potentiometric titration

20-23

was the main approach to investigate the

thermodynamics and sometimes the mechanisms of electron transfer of in enzymatic
processes. This method is not suitable for studying kinetics of reactions. Another
drawback is that this approach requires relatively large quantity of enzyme samples.
More recently, direct electrochemistry

24-26

of metalloproteins became more popular

because of the speed and wealth of inforamtion that it provides. This approach is much
more versatile and powerful; if not only gives access to thermodynamic data, but it also
provides information on the kinetics of electron transfer.
Direct electrochemical study of metalloproteins requires direct electron transfer
between protein and electrode surface. The surfactant thin film methodology

27, 28

was

developed to study a variety of metalloproteins. The film-forming surfactant employed in
our work and widely used in other investigations
ammonium bromide (DDAB).
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16, 28-31

is didodecyl dimethyl

2.2 Experimental Design
2.2.1 Materials
Horse heart myoglobin is purchased from Sigma. Myoglobin is purified as in
reference32

before

use.

Didodecyldimethyl-ammonium

bromide

(DDAB)

and

nitromethane are from Acros Organics.
Nitrogen gas is purchased from PRAXAIR. Deionized water is obtained from a
Barnstead Nanopure system with a resistivity greater than 18 MΩ·cm. Pyrolytic graphite
(Advanced Ceramics) is the material for working electrodes. Homemade working
electrodes are prepared as in reference,16 and the fabrication process is described below.
2.2.2 Fabrication of the pyrolytic graphite (PG) working electrode
A pyrolytic graphite block is cut perpendicularly to the basal plane using a diamond
core drill bit to make a cylinder of the graphite with diameter of ~3.2mm. The cylinder
lock is then cut into small cylinders with a scalpel blade along the basal plane to make
each cylinder about 3 mm tall. A piece of copper wire (precut 15 cm) is connected to one
end of the graphite cylinder using conductive epoxy, and allowed to dry. The graphite
cylinder is then inserted in a glass tubing (ID=4mm) and set in place with non-conductive
epoxy and allowed to dry, figure in appendix B. The non-conductive epoxy is also used
to seal the gaps between graphite and glass. The finished electrode is then polished and
cleaned.
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2.2.3 Electrode modification
Myoglobin (Mb) is immobilized in DDAB surfactant film on a basal-plane pyrolytic
graphite (PG) disc electrode28, 33 (surface area is ~0.08 cm2), (Mb/DDAB/PG). Before
film casting, the PG electrode is polished using 400-grit sandpaper followed by 0.3μm
alumina slurry. The polished electrode is then rinsed and sonicated in distilled water.
Mb/DDAB surfactant film is prepared by casting 10μl of 10mM DDAB in H2O followed
by 10μl 0.4mM myoglobin solution. The modified PG electrode is then allowed to dry in
air for more than 12 hours. DDAB emulsion is prepared by dissolving DDAB powder in
deionized water. The emulsion is then sonicated for at least 2 hours or until the solution
becomes clear. Myoglobin buffer solution is prepared by dissolving myoglobin in 0.1M
acetate buffer (pH 5.5) or in other suitable buffers.
2.2.4 Procedures and Apparatus
2.2.4.1 Electrochemical Measurement
Cyclic voltammetry (CV) is an excellent tool to study the heme iron redox activity
through electron transfer. Another electrochemical technique that we use is rotating disk
voltammetry (RDV). This hydrodynamic electrochemical method can provide steady
state current needed to measure true values of the catalytic current. Therefore, it is
routinely used in electrochemical study of enzyme catalysis.34-36
All electrochemical experiments are conducted using a three-electrode system (Figure
2.2) on a BAS 100B electrochemical workstation or CH Instrument. Ag/AgCl (3M KCl)
is used as reference electrode and all potentials are reported versus this reference. A
platinum wire is employed as the auxiliary electrode. Modified PG electrodes are used as
working electrodes of course.
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Figure 2.2 Electrochemical setup

39

All electrochemical experiments are performed in 0.1M acetate buffer (pH 5.5)
containing 0.1M sodium bromide. The solution in the cell is purged with purified
nitrogen for at least 15 min prior to experiments to remove oxygen from the solution. A
nitrogen blanket is maintained to prevent contamination with oxygen from air.
2.2.4.2 Bulk Electrolysis
Bulk electrolysis is performed using a modified large area PG electrode as working
electrodes. The electrode is poised at the potential where the electro catalysis occurs.
Constant stirring is maintained to ensure mass transfer during electrolysis. The amount of
substrate converted during the process is calculated using initial and final concentrations.
2.2.4.3 Mass Spectrometry
A sample of the solution after bulk electrolysis is infused into a Micromass Quattro II
electro-spray triple quadrupole mass spectrometer (ESI-MS) to identify and quantify the
products of the catalytic nitromethane electroreduction. The calibrations of the possible
products are conducted using triethylamine as an internal standard.
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2.3 Results and Discussion
2.3.1 Electrochemistry of Mb/DDAB/PG
A cyclic voltammogram of Mb/DDAB/PG in pH5.5 acetate buffer, Figure 2.3, shows
a pair of well-defined reversible redox couples; the first couple, R1/O1 (Equation 2), is
assigned to FeIII/FeII with a formal potential –0.180V vs. Ag/AgCl. The R2/O2 couple,
(Equation 3) with formal potential –1.052V vs. Ag/AgCl is tentatively assigned to
FeII/FeI.16, 29, 32
R1
⎯⎯→

Mb − Fe III − +1e −1←⎯⎯
Mb − Fe II −
O1

(2)

2
⎯R⎯→

Mb − Fe II − +1e −1←⎯⎯
Mb − Fe I −
O2

(3)

As has been shown in a number of reports the heterogeneous electron transfer is
greatly enhanced in the surfactant film. In fact, as shown in Figure 2.4, when peak
splitting ΔEp for the FeIII/FeII is plotted as a function of scan rate, the ΔEp stays
unchanged in the range of scan rates from 0.001V/s to 1V/s, and then increases as
expected at higher scan rates (i.e. shorter time frame) where electron transfer is
kinetically challenged. Simulation of this behavior provides an estimate of the electron
transfer rate. We find a ks of 0.01 cm/s indicating a fast electron transfer for this large
protein.
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Figure 2.3 Cyclic voltammogram of Mb/DDAB/PG
in pH5.5 acetate buffer at 0.15 V/s.
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Figure 2.4 Plot of ΔEp as a function of scan rate using
Mb/DDAB/PG electrode in pH 5.5 buffer
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2.3.2 Electrocatalytic reduction of nitromethane
The cyclic voltammogram as described earlier dramatically changes after introducing
nitromethane. Figure 2.5a shows the typical voltammogram of Mb/DDAB/PG electrode
in pH5.5 buffer in absence of nitromethane. There are 2 pairs of redox couples assigned
to FeIII/FeII (formal potential at -0.18V vs. Ag/AgCl) and FeII/FeI (formal potential at 1.06V vs. Ag/AgCl), respectively. Upon addition of nitromethane, a new peak, Rc,
appears at -1.0V vs. Ag/AgCl in parallel with the disappearance of the FeII/FeI (Figure
2.5b). A control experiment (Figure 2.5c) is conducted with a DDAB/PG electrode
without embedded Mb as working electrode under the same conditions. The Rc peak
current is significantly higher than that of the control experiment and the Rc peak
potential is more positive compared to the control voltammogram (-1.16V in Figure 2.5c).
The new Rc peak appearing at potentials more positive than FeII/FeI redox couple and the
disappearance of the later are both indicative of an electro catalytic process mediated by
myoglobin.
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Figure 2.5 Cyclic voltammograms of DDAB/PG and Mb/DDAB/PG electrode in pH 5.5
acetate buffer solution at the scan rate 0.15V/s. (a) Mb/DDAB/PG without nitromethane,
(b) Mb/DDAB/PG with 0.4 mM nitromethane, (c) DDAB/PG with 0.4 mM nitromethane.
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Literatures showed that myoglobin maintains its native structure in a certain pH range
when immobilized in the surfactant films such as DDAB.15,

32, 37

However, other

investigations claimed different results. Some reports state that heme is released from
myoglobin in DDAB surfactant film,38, 39 and the electrochemical signals of myoglobin
arise actually from the free heme.
In our hands and under our conditions, myoglobin maintains a native-like structure
and the redox activity observed comes from its intact form. In fact, cyclic voltammetry
performed with chemically denatured (SDS treated) myoglobin on the electrode surface
gives a different behavior. The voltammogram (Figure 2.6a) shows that the previously
well defined 2 redox couples (Figure 2.5a) has drastically changed. Also in support of our
results, the catalytic function of the denatured protein is lost in the presence of
nitromethane substrate. The reductive wave at –1.1V (Figure 2.6b) is the direct
electroreduction of nitromethane. Our results are in support of the fact that myoglobin
retains its native-like structure in our surfactant films.
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Figure 2.6 Cyclic voltammograms of SDS denatured* myoglobin electrode in pH5.5
buffer. (a) 0 mM nitromethane (b) 0.4 mM nitromethane.
*Myoglobin solution was treated with 1% SDS solution prior to electrode modification.
10μl of the SDS treated myoglobin suspension after vortexing was used along with 10μl
DDAB solution to modify a PG electrode (procedure refer to section 2.2.3).
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2.3.3 Effect of nitromethane concentration
The catalytic reduction current obtained from cyclic voltammetry can provide
quantitative information of on turnover and other kinetic aspects in the thin film. Figure
2.7A shows myoglobin-mediated nitromethane reduction catalytic currents at different
substrate concentrations. Catalytic current Icat as a function of substrate concentration [S]
is shown in Figure 2.7B. The plot exhibits linear relationship between Icat and [S] when
[S] is smaller than 0.6 mM. The plot starts to curve down greater concentrations, which is
typical for enzyme saturation kinetics. The plot can be fit to Michaelis-Menten kinetics,
Equation 4.

V =

Vmax × [ S ]
(Michaelis-Menten Equation)
K m + [S ]

(4)

Equation 5 shows the scheme of enzyme-catalyzed substrate transformation. E
symbolizes the enzyme, S the substrate, ES is enzyme-substrate complex, and P is
product.
E+S

k1
k-1

Km =

k−1 + k2
k1

k2
ES ⎯⎯→
E+P

(5)
(6)

Km, as defined in Equation 6, is an indication of the constant of the formation of
enzyme-substrate complex. It also reflects the catalytic constant k2 or kcat, the turnover
number.
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Figure 2.7A Voltammograms of Mb/DDAB/PG electrode in pH 5.5 acetate buffer
solution at a scan rate of 0.15V/s in the presence of (a) 0.3 mM, (b) 0.8 mM, (c) 1.3 mM,
(d) 2.0 mM nitromethane.
Figure 2.7B Catalytic current of nitromethane catalytic reduction by Mb/DDAB/PG as a
function of nitromethane concentration.
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To quantify Km and kcat electrochemically, we need to use the electrochemical form
of Michaelis-Menten equation can be expressed by Equation 7

40

under steady-state

conditions:

I cat =

nFAΓk cat × [ S ]
K m + [S ]

(7)

where Г is the surface concentration of catalyst, F is Faraday’s constant, A is the surface
area of the electrode, [S] is substrate concentration, Km and kcat are the usual MichaelisMenten parameters.
To calculate the total amount of active catalyst on the electrode surface we typically
use an electrochemical technique based on current integration (i.e. charge measurement)
of voltammograms taken at very slow scans.15 The integration of the reductive peak of
FeIII-heme/ FeII-heme from a linear potential scan at 5mV/s gives the amount of active
heme proteins in the surfactant films, Figure 2.8. The average value for Mb/DDAB is
around 21.2 picomoles; accordingly the surface concentration is 2.65 × 10-10 mole/cm2,
which is in the same range of the value reported in the literature.15
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Figure 2.8 Typical linear voltammogram of Mb/DDAB/PG electrode in pH5.5
acetate buffer at scan rate 5mV/s; Integrated area under the voltammogram is shown as
filled.
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Figure 2.9 shows the plots of normalized catalytic current, Icat / nFAΓ , versus
substrate concentration [S] plot of Mb/DDAB-catalyzed reaction. Non-linear fitting the
plots (Figure 2.9) using Equation 7 gives the regression parameters kcat and Km. The
parameters are shown in Table 2.1.
Table 2.1 Regression parameters from Figure 2.9

Myoglobin

Km

kcat

kcat / Km

(mM)

(s-1)

(s-1 · mM-1)

1.9 ± 0.2

20.9 ± 1.8

11.2 ± 2.1

The parameter Vmax / Km (or kcat / Km) is the rate of catalysis at the substrate
concentration [s] close to 0, equation 7, and is usually used to define the catalytic ability
or efficiency of an enzyme.
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Figure 2.9 Catalytic current of Mb/DDAB/PG normalized by catalyst surface
concentration as a function of nitromethane concentration.
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2.3.4 Effect of scan rate
One can study the electron transfer and mass transfer kinetics using diffusioncontrolled technique such as cyclic voltammetry. Increasing scan rate shortens the
timescale within which the catalytic reaction is monitored. As expected the catalytic
efficiency, defined by the ratio Icat / I0 29 is larger at small scan rate and gradually drops as
the scan rate increase, Figure 2.10. This behavior is typical of electrocatalytic process and
can be used to extract kinetic information.
The peak potential of the catalytic wave is plotted as a function of scan rate, Figure
2.11. The figure shows that the catalytic peak shifts negatively with increasing scan rate.
Since the catalysis is triggered within the time scale defined by the scan rate, this shift is
an indication that more energy is required for the catalysis to occur in a higher scan rate.
A chemical and/or an electrochemical step(s) in the catalytic reaction could be rate
determine during the catalysis.
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Figure 2.10 Catalytic efficiency as a function of scan rate.
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Figure 2.11 Catalytic peak potential as a function of scan rate
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2.3.5 Effect of pH
The electroreduction of nitromethane involves protons uptake.5 The catalytic
reduction is also a proton-coupled process, which we will discuss later in the mechanistic
study. Therefore, the availability of protons will affect the catalytic process. We conduct
cyclic voltammetry under a series of pH values to monitor the effect of proton availability
on the myoglobin-mediated reduction of nitromethane.
Figure 2.12A shows that the catalytic current drops with increasing pH. Figure 2.12B
shows that the catalytic current changes slowly from pH 5.5 to pH 9, and then sharply
from pH 9 to pH 11. Studies have shown that nitromethane is polar and exists in different
forms under different pHs.41 The aci-nitro tautomerism of nitroalkane shows the
equilibria of nitronic acid, R1R2C=NO2H (aci form), nitroalkane, and the nitronate anion
R1R2C=NO2- in neutral or basic medium, Equation 8.41
k2
R1R2C=NO2H

-

+

k-1

R1R2C=NO2 + H

R1R2CH-NO2

(8)

k1

k-2

Nitromethane stays in nitro-from under acidic pH and transforms to aci-form in basic
media. The dissociation constant of the aci form of nitromethane to the nitronate anion.42
It is known that the formation of the anion of the aci form of nitromethane in alkaline
solution prevents the reduction.42 This can partially explain the sharp decrease of
catalysis when pH is greater than 9, Figure 2.12B.
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Figure 2.12A Cyclic Voltammograms of Mb/DDAB electrode in the presence of 0.1mM
of nitromethane in different pH solution.
Figure 2.12B Catalytic current, Icat, as a function of pH.
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It is known that water is the heme ligand in acidic environments and hydroxide
becomes the ligand under basic conditions.27 Thus the fast drop of catalysis is not only
caused by the availability of proton, but also the competitively binding of nitromethane
with hydroxide ion to the heme iron.27 At pH 11, the catalytic current is not observed,
indicating that the proton concentration cannot support the catalysis.
The catalytic peak potential is affected by the pH, Figure 2.13. The shift of reduction
potential with pH may reflect the change of ligand binding properties to the heme as well
as the change of proton availability that drives the catalysis. There is also a clear turning
point at pH 9.5 in Figure 2.13, which shows a change of the slope of pH dependency. The
sharp decrease of catalytic peak potentials can be partially due to the intrinsic
dissociation of nitronic acid to nitronate anion, which is difficult to reduce.

59

Catalytic Reduction Potential mV

-1000

-1050

-1100

5

6

7

8

9

10

11

pH

Figure 2.13 Potential of the catalytic reduction of 0.1 mM nitromethane on
Mb/DDAB/PG electrode as a function of pH.
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2.3.6 Number electrons per nitromethane molecule in myoglobin-mediated catalysis
We used the bulk electrolysis method to measure how many electrons pass through
Mb/DDAB/PG and how much nitromethane is consumed. Bulk electrolysis is performed
at the level of the catalytic peak at -1.0 V vs. Ag/AgCl under constant stirring. A large
surface PG electrode modified with Mb/DDAB is used as a working electrode. The
starting concentration of nitromethane is 1.96 mM in 5 mL of solution, and the
concentration of nitromethane after the process is measured by an electrochemical
calibration method. The consumption of nitromethane is then derived, and the total
number of nitromethane molecules consumed can be calculated. The total charge passed
during the electrolysis is recorded by the electrochemical station. The electrons per
nitromethane molecule can therefore be acquired.
The stoichiometric study derived that the ratio of total charges to the reduced
molecules is close to 4:1, implying 4 electrons per nitromethane molecule consumed, and
implies that nitromethane electroreduction yields mainly methyl hydroxylamine. Table
2.2 shows the results of the number of electrons per molecule after bulk electrolysis for
various trials.

Table 2.2 Calculation of number of electron per nitromethane molecule
Total electrons Total nitromethane
passed
molecules reduced

Electrons per
molecule

Trial 1

7.20 × 1018

1.54 × 1018

4.68

Trial 2

7.33 × 1018

1.65 × 1018

4.44

Trial 3

7.62 × 1018

1.80 × 1018

4.23
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Average
(mean ± SD)

4.45 ± 0.23

2.3.7 The products of catalytic reduction of nitromethane
In order to identify the products of the catalytic reduction, which is critical for the
understanding of the reaction mechanism, we used a mass spectrometric method. The
mass spectrometric technique we used to analyze the products of electrolysis of
nitromethane electroreduction is semi-quantitative. Calibration curves (Figure 2.14) of
the possible products are prepared using authentic compounds with triethylamine as the
internal standard. The mass spectrometry analysis of the solution after bulk electrolysis
shows that methyl hydroxylamine is the dominant product; the other possible reductive
product methylamine was not detectable by the MS technique used (the detection limit is
below 1 μM for this compound, Figure 2.14b).
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Figure 2.14 Calibration curve of methyl hydroxylamine (a) and
methylamine (b) using QQQ-ESI mass spectrometer
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2.3.8 Characterization of the intermediate of the catalytic reaction
2.3.8.1 UV-vis spectroscopy
We resorted to UV-vis spectroscopy to investigate the reaction between nitromethane
and heme group and characterize possible intermediates complexes during the catalytic
reduction of nitromethane. Mb-FeIII (Soret at 409nm, data not shown) is reduced to MbFeII (Soret at 434nm, Figure 2.15) by adding excess amount of sodium hydrosulfite. The
addition of nitromethane causes an absorption decrease at 434nm with concurrent
absorption increase at 424nm giving an isosbestic point at around 430nm. The species
with 424nm absorption is identical to that of ferrous myoglobin-nitrosomethane complex
characterized in solution.43-45
The heme(FeII)-nitrosomethane complex was studied by Mansuy’s group in their
investigation of the reaction of aliphatic nitro compounds with myoglobin and
hemoglobin under reducing conditions.46 Other reports43,

47

also stated that ferrous

hemoproteins bind to nitrosoalkanes to form stable complexes that were characterized by
UV-vis spectroscopy.
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Figure 2.15 Evolution of the absorption spectra of reduced 10μM of Mb solution after
addition of 25 mM nitromethane. Spectra were taken every 10s.
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Nitromethane itself bind neither to Heme(FeIII) and nor to Heme(FeII).45 Consistent
with these results, UV-vis experiments show no reaction between nitromethane and
Heme(FeIII) (Figure 2.16A) or Heme(FeII) (Figure 2.16B).
To examine if the myoglobin ferrous nitrosomethane complex forms during our
heme-mediated electroreduction process, we poised a DDAB/PG electrode at –0.8 V in
pH5.5 acetate buffer in the presence of nitromethane and Mb(FeII). The direct
electroreduction of nitromethane at PG electrode will transform nitromethane to
potentially nitrosomethane under these conditions; the latter should bind to Mb(FeII) to
form the complex if any. UV-vis spectrum is taken before the catalysis and every 2
minutes during the electrolysis. A complex with UV-vis features similar to those assigned
by Mb-nitrosomethane forms during our reduction process triggered electrochemically.
The results confirm that the myoglobin ferrous nitrosomethane complex is formed after
the electrolysis, Figure 2.17.
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Figure 2.16A UV-vis spectra of myoglobin in pH 5.5 buffer. (a) 0 mM of nitromethane,
(b) 2 mM of nitromethane.
Figure 2.16B UV-vis spectra of reduced myoglobin in pH 5.5 buffer. (a) 0 mM of
nitromethane, (b) 2 mM of nitromethane.
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Figure 2.17 UV-vis spectra of Mb(FeII) with nitromethane in pH 5.5 buffer solution. (a)
Mb(FeII) + nitromethane before electrolysis, (b) after 2 minutes of electrolysis, (c) after 4
minutes of electrolysis, (d) after 6 minutes of electrolysis, and (e) after 15 minutes of
electrolysis.
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2.3.8.2 Electrochemical signature of the heme ferrous nitrosomethane complex
Since the ferrous nitrosomethane complex of myoglobin forms under our
experimental conditions, we asked whether we could characterize it electrochemically.
Under anaerobic condition, we preformed the nitrosomethane-heme(FeII) by reacting
myoglobin solution with nitromethane in the presence of excess amount of dithionite.
The reaction product was then used to modify our PG electrode under N2. The
modification procedure refers to section 2.2.3. We performed cyclic voltammetry in pH 6
buffer in the range of –0.8 to –1.1 V at a scan rate of 0.8 V/s. The myoglobin and
nitrosomethane is expected to separate if Mb-nitrosomethane complex is oxidized.16
Hence, all our experiments are performed under N2, and potential scan starts at –0.8 V to
avoid the chemical or electrochemical oxidation of the Mb-nitrosomethane complex. Fast
scan prevents the electroreduction from completion, which will cause dissociation of the
complex and irreversibility. We were able to observe a reversible redox couple at the
potential of –0.924 V (Figure 2.18) for this complex inside a narrow electrochemical
window. The possible reaction of this reversible electrochemical reaction is showed in
Equation 9.
O
H3C

N

Hm(FeII)

O

+e-

H3C

N

Hm(FeII)
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(9)

3

Current μA

2

1

0

-1
-0.8
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-1.0

-1.1

Potential V

Figure

2.18

Baseline-subtracted

cyclic

voltammogram

of

Mb(FeII)-

nitrosomethane/DDAB/PG electrode in pH6 buffer solution at a scan rate of 0.8 V/s.
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2.3.9 Mechanistic insights on the heme-mediated catalytic electroreduction of
nitromethane
According to the fact that neither ferric myoglobin nor ferrous myoglobin can bind
nitromethane, and the myoglobin as the catalyst in the process needs to interact with
substrate, the nitromethane substrate should change its state before the catalysis can
happen. It is known that the first step of direct electroreduction of nitromethane forms
nitrosomethane, which is the substrate for Mb(FeII) to form the myoglobinnitrosomethane complex as we discussed before. Another evidence is that the myoglobinmediated electroreduction peak starts at -0.75 V as shown in Figure 2.5, and the direct
reduction peak of nitromethane on a DDAB only electrode starts also at -0.75 V vs.
Ag/AgCl, Figure 2.19. It is an indication that the catalytic process is also triggered by the
direct electroreduction of nitromethane. The following step will be the formation of
Mb(FeII)-nitrosomethane intermediate. The electroreduction of the intermediate will be
the next step. Based on the voltammetric behavior observed, the proposed catalytic
reduction pathway is as follow:
(a) heme reduction:
Heme(FeIII) + e- Æ Heme(FeII)

(10)

(b) Heme-mediated nitromethane electroreduction:
k1
CH3NO2 + 2 e- + 2 H+
CH3N=O + H2O
k-1
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Figure 2.19 Cyclic voltammograms of DDAB/PG electrode in pH 5.5 acetate buffer
solution at the scan rate 0.15V/s. (a) 0 mM nitromethane (b) 0.2 mM of nitromethane
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O

CH3N=O + Heme(FeII)
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H3C

N

(12)

Heme(FeII)
O
H3C

+ 2 e- + 2 H+

N

kS2

CH3NHOH + Heme(FeII)

(13)

Heme(FeII)
OH
H3C

N

k2

Heme(FeII) + CH3NHOH

(14)

H
Heme(FeII)

In step (a), Heme-Fe(III) gains electrons and reduces to Heme-Fe(II), Equation 10.
Step (b) shows the catalytic reduction of nitromethane using Heme-Fe(II) as a catalyst.
During the negative potential scan of the cyclic voltammetry, nitromethane gains 2
electrons from the electrode coupled with 2 protons and forms an unstable
nitrosomethane CH3N=O, Equation 11.
Nitrosomethane binds to typical hemoproteins irreversibly.43 The lone pair electrons
on the nitrogen of the nitrosomethane readily coordinate the ferrous heme to from a stable
ferrous-nitrosomethane complex, Equation 12. It is this intermediate that was
characterized spectroscopically and electrochemically in this work. A further 2-electron
process coupled to two protons reduces this intermediate to regenerates the catalyst along
with the reduced product, Equation 13. A dissociation step gives out the final product,
methyl hydroxylamine, with the release of the catalyst at the FeII state, Equation 14.
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2.3.10 Heterogeneous and homogeneous reaction rates
The proposed heme-mediated nitromethane electroreduction pathway involves
chemical and electrochemical reactions; the determination of the kinetic parameters of
the processes can be obtained by simulation of cyclic voltammograms using Digisim
software package (BAS).
One of the chemical reactions in the catalytic process is described in Equation 11 with
the forward rate constant k1, and the backward rate constant k-1, and the other is described
in Equation 14 with rate constant k2. The electrochemical reactions include direct
electroreduction of nitromethane, displayed in Equation 11, with the heterogeneous
electron transfer rate constant kS1 and the catalytic electrochemical process given in
Equation 13 with an electron transfer rate constant kS2. The simulated parameters are
shown in table 2.3 using our proposed mechanism.
By definition, k2 is equal to kcat and Km is equal to (k-1 + k2) / k1. The parameters of
simulation k1, k-1, and k2 shown in Table 2.3 are in agreement with the Michaelis-Menten
parameters kcat and Km listed in Table 2.1. The simulated voltammograms fit the
experimental data properly and are shown in Figure 2.20. Digisim simulations validate
the kcat and Km values derived from catalytic current data and further confirm our
proposed mechanism of the heme-mediated catalysis.

Table 2.3 Digisim® simulation parameters of myoglobin-catalyzed nitromethane
electroreduction

Myoglobin

k1 (s-1· M-1)

k-1 (s-1)

k2 (s-1)

kS1 (cm/s)

kS2 (cm/s)

1 × 104

0.1

20

3.8 × 10-7

0.01
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Figure 2.20 Digisim® simulation of cyclic voltammograms. (

□

) simulated

voltammograms, (—) experimental voltammograms using the proposed mechanism.
Cyclic voltammogram of Mb/DDAB/PG is obtained in the presence of 0.4 mM
nitromethane in pH5.5 buffer solution at (a) 200 mV/s, (b) 400 mV/s, and (c) 600 mV/s.
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2.4 Conclusion
Myoglobin can be used to study the catalytic activation of xenobiotic carcinogens
such as nitromethane. The DDAB surfactant thin film method is suitable for
metalloprotein immobilization. Myoglobin and cytochrome P450s share some common
characteristics that come from the iron center of the porphyrin. Our mechanistic
investigation showed the existence of a ferrous nitroso complex as the intermediate
during Mb-mediated catalytic reduction of nitromethane. The product of Mb-mediated
electroreduction of nitromethane is methyl hydroxylamine, and the catalysis is a 4electron process. The catalytic reduction process is examined under the experimental
conditions such as scan rate, substrate concentration and pH. The kinetic information of
the catalysis was extracted from our electrochemical experimental data. The Digisim
software can be used to obtain the heterogeneous and homogeneous reaction rate
constants using the cyclic voltammograms from our experiments.
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CHAPTER III
CATALYTIC ACTIVATION OF NITROMETHANE USING VARIOUS
HEMOPROTEINS AND HEMIN

3.1 Introduction

The study of myoglobin-catalyzed nitromethane electroreduction gave us a general
understanding of how hemoprotein can facilitate the electro activation of nitromethane.
But what is the function of the protein parts of myoglobin, and whether there are
differences between using myoglobin and using a real P450 enzyme in this catalytic
process are still open questions. In this part of study, we use heme group without protein
(hemin) and nitric oxide synthase (NOS), an enzyme that has a proximal cysteine thiolate
akin to P450 enzymes, to catalyze the electroactivation of nitromethane and compare the
results of myoglobin-mediated processes. Through the comparison, we may evaluate the
effect of the protein shell and the effects of different heme ligands in different
hemoproteins.
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Hemin is the bare heme group and the prosthetic group in all heme proteins. It may
have the catalytic properties of heme proteins without a protein shell (Figure 3.1).
Understanding the intrinsic catalytic activation of nitromethane by hemin is of critical
importance in order to better understand the role of the protein part of P450s.
In the absence of protein structure, iron in hemin does not have the fifth ligand,
therefore the ligand binding to heme and its open structure may bring different electron
transfer, mass transport, and overall kinetics. Some studies reveal its ability to electrocatalyze hydrogen peroxide, nitrite, nitric oxide, nitrous oxide, other nitro-compounds,
and organic halides reduction. 1-5
We also chose the nitric oxide synthase oxygenase (NOSoxy, Figure 3.2) to catalyze
the electro-activation of nitromethane. Compared to hemin molecule, NOSoxy has the
protein shell, and the heme group is held by a cysteine thiolate coordination at the
proximal site just like P450 enzymes. Those differences could affect substrate
accessibility and substrate binding affinity to the heme, therefore change the catalytic
process. Also, the catalytic activation of nitroalkane needs protons, hence we can observe
the effect of protein structure on proton transfer.
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Figure 3.1 Structure of Hemin
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Figure 3.2 Murine inducible nitric oxide synthase oxygenase domain with inhibitor
Image from: PDB 1DF1
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NOS is a very important enzyme responsable for nitric oxide biological production.
Three isoforms of nitric oxide synthase are currently known; the family includes
inducible NOS (iNOS), neuronal NOS (nNOS), and endothelial NOS (eNOS). We chose
inducible NOS in our study, which is used by the immune system to produce NO to fight
pathogens.
Full-length NOS enzymes are heme flavoproteins belonging to the P450
superfamily 6. Their structure contains two domains on the same polypeptide: 1) an
oxygenase domain, with specific binding sites for the heme active center, the
tetrahydrobiopterin (BH4) cofactor, and arginine substrate 7, and 2) a reductase domain,
which contains binding sites for nicotinamide adenine dinucleotide phosphate (NADPH),
flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) 7.
Cytochrome P450 Reductase (CPR) and the NOS reductase domain both have the
same prosthetic group FAD and FMN and the NADPH binding site.8 The oxygenase
domain of NOS is also a heme-containing protein like cytochrome P450s. The biological
functions of these two proteins are different but the basic catalytic functions of the
functional groups are similar. FAD and FMN in reductase domain shuttle electrons from
NADPH to heme group in oxygenase domain to activate heme, and the activated heme
will perform the transition of substrate to product. Under aerobic condition, similar to
other monooxygenases, NOS catalytic NO production is initiated by activation of
molecular oxygen by NOS-heme to form an oxyferroheme complex9 (Scheme 3.1), just
like cytochrome P450 (Scheme 1.1). So this enzyme can closely mimic cytochrome P450
catalytic activity.
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Scheme 3.1 Monooxygenation step of biological NO production by NOS9
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In this study, we chose only oxygenase domain of NOS to study P450 enzyme
activity because the electrons needed to activate heme are provided by the electrode.
NOS enzymes structurally resemble the nitroalkane-metabolizing P450 enzymes, and
nitroalkanes could be potential substrates for NOS too. Evidence shows that nitroalkanes
or their metabolites such as hydroxylamines could interact with NOS-heme
Nitroalkane can also be oxidized by oxygen catalyzed by a flavoprotein
hydroxylamines have shown to have vasodilatory properties

11

10

.

. In addition,

12, 13

, possibly through a

metabolic path leading to NO release.
In this work, hemin and NOS are immobilized on PG electrodes in DDAB thin film
as we did with myoglobin in the previous study. The electrocatalysis is characterized
electrochemically and the differences of enzymatic activities are discussed.

90

3.2 Experimental design

3.2.1

Materials

Hemin

is

purchased

from

Sigma

and

used

without

further

process.

Didodecyldimethyl-ammonium bromide (DDAB) and nitromethane are from Acros
Organics. Oxygenase domain of inducible nitric oxide synthase (iNOSoxy) is expressed
and purified in our laboratory.
Nitrogen, compressed from PRAXAIR. Deionized water is obtained from a Barnstead
Nanopure system with a resistivity greater than 18 MΩ · cm. Pyrolytic graphite
(Advanced Ceramic) is the material for the working electrodes. Homemade working
electrodes are prepared as in reference.5
3.2.1.1 Expression and Purification of Recombinant iNOSoxy
The expression and purification of the oxygenase domain is conducted in house using
classic Escherichia coli expression systems.
The experimental protocol that we use is for iNOSoxy expression has been described
in the literature

14

; it was adopted as such but with minor modification. Briefly,

recombinant wild-type iNOSoxy proteins with a His6 tag attached to their carboxyl
terminus are overexpressed in Escherichia coli strain BL21 (DE3) using a modified
pCWori vector. The expression of the protein is typically induced when the culture
reaches an optical density of 0.6 at 600 nm. The cells are harvested after (12-24) hours
induction and then suspended in the lysis buffer. After sonication, the suspension is
centrifuged and the crude extract is loaded into a Ni-nitrilotriacetate-Sepharose 4B
column. Bound protein was eluted with elution buffer (160 mM Imidazole, 10μM
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H4B/AA, 1mM L-Arginine, 1mM PMSF/ethanol). The collected fractions containing
iNOSoxy are then pooled and concentrated. The final concentrated protein solution is
then dialyzed at 4°C to desalt and stored in aliquots (10% glycerol added) at -80°C.

3.2.2

Electrode modification

Hemin (Hm) or iNOSoxy is immobilized in the surfactant film on a basal-plane
pyrolytic graphite (PG) disc electrode4, 15 (surface area is 0.08 cm2), and the modified
electrodes are referred to as Hm/DDAB/PG and iNOSoxy/DDAB/PG. Before coating, the
PG electrode is polished using 400 grit sandpaper followed by 0.3μm alumina. The
polished electrode is then rinsed and sonicated in distilled water. Hm/DDAB surfactant
film is prepared by casting 10μl Hm/DDAB surfactant solution on the PG electrode and
dried in air for more than 12 hours. Hm/DDAB surfactant solution is prepared by mixing
0.4 mM hemin solution with 10mM DDAB H2O emulsion is a 1:1 volume ratio. DDAB
solution is prepared by dissolving DDAB powder in deionized water and sonicating for 2
hours. Hemin solution is prepared by sonicating hemin in 0.1M acetate buffer (pH 5.5,
0.05 M NaBr is added) for 2 hours to make a homogeneous dispersion. The hemin
dispersion is mixed with DDAB emulsion immediately after sonication. iNOSoxy/DDAB
surfactant film is prepared by casting 5μl of 10mM DDAB H2O solution followed by 5μl
of iNOSoxy buffer solution. iNOSoxy buffer solution is prepared using the protocol
described above.
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3.2.3

Electrochemistry

The electrochemical techniques used in this work are the same as in the previous
study. The apparatus keeps the same.

3.2.4

UV-Vis spectroscopy

UV-Vis spectroscopy is used in this work to determine the concentration and
structure character of iNOSoxy protein.
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3.3 Results and discussion
3.3.1 Spectroscopic characterization of iNOSoxy/DDAB film
Prior to electrochemical measurements, we first studied whether the native form of
iNOSoxy is conserved in the surfactant environment. To this end, we used UV-Vis
spectroscopic characterization using the typical Soret band (Figure 3.3), as well as
Fourier Transform Infrared Spectroscopy (FTIR) using the amide I and amide II IR bands
(results not shown). A mixture of equal volumes of a purified sample of enzyme (~60 μM)
and DDAB suspension (10 mM) is cast on transparent indium tin oxide (ITO) glass slide
to prepare the iNOSoxy/DDAB film. As with graphite electrode preparation, the cast film
on ITO is typically left to dry slowly in a closed vessel overnight, and then in open air.
For iNOS heme domain, the typical low-spin iron-heme Soret bands is at around 422 nm
16

. Our results show that both iNOSoxy/DDAB on ITO slide and the control iNOSoxy in pH

7 phosphate buffer show the characteristic Soret absorption at 421 nm, Figure 3.4. These
results show that the native form of iNOSoxy is mainly conserved in the DDAB
surfactant film. Also, addition of arginine, which binds above the Fe-heme at the active
site switches the spin state of the iron center from low to high spin. This process can be
easily monitored through a typical shift of the Soret band to about 396 nm. We observe
similar shift with iNOSoxy immobilized in the bilayered DDAB film. This indicates
clearly that the substrate arginine specifically recognizes its binding site in the film
environment. These spectroscopic results show that the native structure of the embedded
iNOSoxy enzyme is still conserved.
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Figure 3.3 UV-vis absorption spectra of (a) iNOSoxy in buffer solution and (b)
iNOSoxy/DDAB film on a transparent ITO slides.
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To further confirm the native form of NOS in the DDAB environment, we analyzed
the effect of DDAB on the position and shape of the amide I and amide II, which
typically reflect the state of the secondary structure of globular proteins. To this end, we
used FTIR spectroscopy on films cast on a diamond crystal. Our results show that the
shape and position amide I and II are not affected by the presence of DDAB (results not
shown).
Together, our spectroscopic characterizations of iNOSoxy/DDAB films, confirm that
the native structure of iNOSoxy in the surfactant thin film is conserved, and that the
immobilized enzyme can still interact and recognize analytes added in the solution bulk.

3.3.2 Electrochemistry of Hm/DDAB/PG, iNOSoxy/DDAB/PG, and Mb/DDAB/PG
Figure 3.4 shows the voltammograms of Hm/DDAB/PG, iNOSoxy/DDAB/PG, and
Mb/DDAB/PG in buffer solution. The direct electrochemistry of each electrode shows
two fast and reversible redox couples that are characteristics of the heme redox centers.
The formal potentials of FeIII/FeII and FeII/FeI redox couples for Hm/DDAB are –0.195V
and –1.038V vs. Ag/AgCl respectively, for iNOSoxy/DDAB these couples are at
–0.184V and –1.055V, respectively, and for Mb/DDAB these are found at –0.180V and
–1.052V. The iNOSoxy/DDAB results are comparable with Udit’s work using a similar
experimental approach17. The difference in redox potential can be only due to the
different residues or ligands in the heme vicinity of hemoprotein or hemin.
Although we try to use the same concentration of heme (or protein) solutions to
modify the electrodes, the surface concentration of heme group for each type of electrode
will be different. As can be seen the reductive or oxidative peak area of FeIII/FeII redox
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couple of the Hm/DDAB electrode is bigger than that of iNOSoxy/DDAB or Mb/DDAB
electrode. The peak area is proportional to the amount of electroactive species in the film.
Therefore, the surface concentration of heme for Hm/DDAB electrode is higher than that
of iNOSoxy/DDAB or Mb/DDAB electrode. iNOSoxy/DDAB and Mb/DDAB electrodes
show similar surface concentration of heme group. The difference in surface
concentrations can be a problem when comparing the catalytic currents for different
catalysts because the amount of catalyst that participates in the catalysis is not the same.
To eliminate the effect of concentration differences, the catalytic current is normalized by
dividing the catalytic peak by the reductive or oxidative peak area (or peak height if the
peak widths are similar) of FeIII/FeII redox couple of the same electrode. It also eliminates
the deviation among the same type of electrodes.
To quantify total amount of active catalyst on the electrode surface we use the method
described in previous study. The results show that The average values for Hm/DDAB and
iNOSoxy/DDAB film are around 38.1 picomoles and 19.0 picomoles, respectively;
accordingly the surface concentrations are 4.76 × 10-10 mole/cm2 for Hm/DDAB/PG and
2.37 × 10-10 mole/cm2 for iNOSoxy/DDAB/PG. The average surface concentration of
active heme for Mb/DDAB/PG is 2.65 × 10-10 mole/cm2 from previous research.
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Figure 3.4 Cyclic voltammograms of heme(protein)-modified PG electrode in pH 5.5
buffer at 0.15V/s. (a) Hm/DDAB/PG, (b) Mb/DDAB/PG, and (c) iNOSoxy/DDAB/PG.
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Not only the formal potentials and the amount of active heme are different for each
heme (or protein), the electron transfer kinetics also differs between Hm/DDAB and
Mb/DDAB. To compare the electron transfer kinetic of Hm/DDAB electrode within the
film with that of Mb/DDAB electrode, cyclic voltammetry is conducted from 0.2V to –
0.6V for 2 continuous cycles, and only the second cycle of the voltammogram is used to
obtain peak separation data (ΔEp) used in kinetic assessments.
When we compare the 2 curves in Figure 3.5, we see that both ΔEp(Mb) and ΔEp(Hm)
stay unchanged in the range of scan rate from 0.001V/s to 1V/s, indicating fast reversible
electron transfer kinetics. The electron transfer tat is typically measured at the onset of
the abrupt increase of ΔEps at high scan rates. Hemin shows higher ΔEp in every scan rate
we tested. At the scan rate that is lower than 1V/s, the ΔEps of Hm/DDAB and
Mb/DDAB are 50-60mV and 22-25mV, respectively. In the high scan rate (greater than
1V/s) region, Hm/DDAB system displays increasing ΔEp with a relatively steeper
increase than from Mb/DDAB electrode. These data suggest that Hm/DDAB have lower
heterogeneous electron transfer rate than that of Mb/DDAB within the thin film.
The same experiment with iNOSoxy/DDAB was performed. However, due to the
poor stability of the protein film under the condition of extremely low scan rate, full set
of data could not be obtained. Hence, the iNOSoxy/DDAB data was not included in the
comparison above.
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Figure 3.5 ΔEp as a function of scan rate. (a) Mb/DDAB/PG; (b) Hm/DDAB/PG
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3.3.3 Comparison of iNOSoxy-mediated nitromethane electroactivation with
myoglobin-mediated, and bare heme-mediated activations.
3.3.3.1 Electroreduction of nitromethane by the different heme-based catalysts
The Hm/DDAB and iNOSoxy/DDAB systems can also catalyze the electroreduction
of nitromethane as Mb/DDAB did in the previous study. Figure 3.6A(b) shows the
catalytic reduction peak Rc of Hm/DDAB at –0.964 V in the presence of 0.4 mM of
nitromethane. As a bare hemin-mediated catalysis, the catalytic current of Hm/DDAB is
the highest among the 3 catalysts. The high surface concentration of heme group is an
obvious reason. However, once normalized with the amount of heme, Hm/DDAB still
exhibits the highest turnover rate; this will be discussed later. Figure 3.6B(b) shows the
catalytic reduction peak Rc of iNOSoxy/DDAB at –1.060 V. It displays a notable higher
catalytic current compared to the catalysis mediated by Mb/DDAB (Figure 3.6C) even
with slightly lower amount of heme group in the film. The factor that contributes to this
might be the protein structure difference; so the accessibility to heme for iNOSoxy may
be easier than that of myoglobin. Therefore, the mass transport is faster in
iNOSoxy/DDAB system than in Mb/DDAB.
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Figure 3.6A Cyclic voltammograms of DDAB/PG and Hm/DDAB/PG electrode in pH
5.5 acetate buffer solution at the scan rate 0.15V/s. (a) Hm/DDAB/PG without
nitromethane, (b) Hm/DDAB/PG with 0.4 mM nitromethane, (c) DDAB/PG with 0.4
mM nitromethane.
Figure 3.6B Cyclic voltammograms of DDAB/PG and iNOSoxy/DDAB/PG electrode in
pH 5.5 acetate buffer solution at the scan rate 0.15V/s. (a) iNOSoxy/DDAB/PG electrode
without nitromethane, (b) iNOSoxy/DDAB/PG electrode with 0.4 mM nitromethane, and
(c) DDAB/PG electrode with 0.4 mM nitromethane.
Figure 3.6C Cyclic voltammograms of DDAB/PG and Mb/DDAB/PG electrode in pH
5.5 acetate buffer solution at the scan rate 0.15V/s. (a) Mb/DDAB/PG without
nitromethane, (b) Mb/DDAB/PG with 0.4 mM nitromethane, (c) DDAB/PG with 0.4 mM
nitromethane.
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Some reports claim that the electronic signal from a hemoprotein modified electrode
is from hemin that is released from hemoprotein. We already tested SDS denatured
myoglobin electrode in the previous study, and here we apply the same treatment to a
hemin-modified electrode, and the results are shown in Figure 3.7B. The electrochemical
activity of Hm/DDAB (Figure 3.7A) is not changed with or without nitromethane
substrate. Therefore, hemoproteins should be intact when being modified to PG electrode
to perform catalysis.
Some previous electrochemical investigations report on critical residues around the
active site of hemoprotein.18 Also, a pH study of myoglobin-modified electrodes has
shown that the electrochemical activity is closely related to the pkas of key residues of the
protein.19-21 These results have showed that the protein and hydrogen-bonding network
that it provides are involved in the electron transfer process.
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Figure 3.7A Cyclic voltammograms of SDS denatured myoglobin electrode in pH5.5
buffer. (a) 0 mM nitromethane (b) 0.4 mM nitromethane.
Figure 3.7B Cyclic voltammograms of SDS treated hemin electrode in pH5.5 buffer. (a)
0 mM nitromethane (b) 0.4 mM nitromethane.
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3.3.3.2 The effect of nitromethane concentration
We collected data from the experiments with iNOSoxy, hemin, and myoglobin, and
plotted the normalized catalytic current as a function of substrate concentration
(Michaelis-Menten plot, Figure 3.8) for these three different catalysts. The hyperbolic
plot of each catalyst is then fitted into the electrochemical form of Michaelis-Menten
equation (Equation 2.7) to obtain the parameters of kinetics.
After data processing (Table 3.1), iNOSoxy shows the highest catalytic ability and the
lowest catalyst-substrate dissociation constant Km for the catalytic reaction. On the
contrary, hemin has the highest Km and highest turnover number Kcat (more than two
times higher than that of iNOSoxy), but the overall catalytic ability is not better than
iNOSoxy. iNOSoxy and myoglobin have similar catalyst-substrate stability, maybe
because of the structural similarity of the substrate binding site of their heme centers.
Hemin, on the other hand, lack the proximal fifth ligand and the protein shell, which may
affect binding affinity and substrate accessibility to the heme iron.
Table 3.1. Non-linear regression parameters from Figure 3.8
Km
(mM)

kcat
(s-1)

kcat / Km
(s-1 · mM-1)

Hemin

4.4 ± 0.5

68.3 ± 6.3

15.6

iNOSoxy

1.7±0.2

28.1 ± 2.2

16.5

Myoglobin

1.9 ± 0.2

20.9 ± 1.8

11

105

Icat' / nFAΓ s

-1

(1)
(2)
(3)

5

0.0

0.5

1.0

1.5

[S] mM
Figure 3.8 Normalized catalytic current as a function of substrate concentration.
(Michaelis-Menten plot) (1) Hm/DDAB, (2) iNOSoxy/DDAB, and (3) Mb/DDAB.
Icat’ is the catalytic current measured at the scan rat of 150 mV/s.
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3.3.3.3 The effect of scan rate
From the scan rate dependency studies of these three heme-based catalyst, one
can see that NOS-mediated reaction has the steepest drop of catalytic efficiency
compared to the hemin- and myoglobin-mediated ones in the scan rate range from 5mV/s
to 1V/s, Figure 3.9. In the range from 1V/s to 20V/s, the catalytic efficiency of NOS or
myoglobin-mediated reaction drops only slightly. The protein shell is iNOSoxy may play
a role in the steep drop of catalytic efficiency in the 5 mV/s to 1 V/s range. In fact,
protein shell controls substrate access to the active site, and thus directly affects mass
transport. This is in line with the behavior of myoglobin, with relatively open active site
compared to iNOSoxy, and which exhibits a moderate drop in catalytic current. At the
other extreme, bare hemin, with a complete open access, exhibits only a gradual drop in
catalytic current.
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Figure 3.9 Catalytic efficiency as a function of scan rate. (1) Hm/DDAB/PG (2)
iNOSoxy/DDAB/PG (3) Mb/DDAB/PG.
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3.3.3.4 The effect of pH
The pH dependency studies show clear proton dependency for hemin and hemeprotein-mediated catalysis, Figure 3.10. Hemin-mediated reaction exhibits the fastest
dropping of catalytic efficiency with increasing pH, and NOS- or myoglobin-mediated
reaction has a slower dropping rate. Literature suggests that the large number of hydrogen
bonds within the protein molecule may provide extremely efficient means of proton
transfer,22 and protonation and deprotonation of the amino acids surrounding the heme
group of hemoprotein has been shown to affect proton coupled electron transfer
process.19,

23-27

Also, the proton coupled electron transfer might be controlled by the

protonation state of the amino acids23-25. The protein shell of iNOSoxy or myoglobin
would also mediate proton transfers in this reaction, which could act as a local buffer
counteracting the change in bulk pH and make the reaction relatively less dependent on
pH, as observed.
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Figure 3.10 Catalytic efficiency of nitromethane catalytic reduction as a function of pH
in the presence of 0.1mM nitromethane mediated by (1) Hm/DDAB/PG, (2)
iNOSoxy/DDAB/PG, and (3) Mb/DDAB/PG
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3.3.4 Final products of hemin-mediated catalysis versus hemoprotein-mediated
catalysis
Bulk electrolysis experiments coupled with mass spectrometric analysis as we used
in the previous study show that the final product of hemin or myoglobin-mediated
catalysis is methyl hydroxylamine. The number of electrons per nitromethane molecule in
the electroreduction is close to 4 to 1 in both cases. The trials are shown in Table 3.2.
We also did the experiment with iNOSoxy/DDAB electrode. Unfortunately, because
of the vigorous convection applied in the bulk electrolysis, iNOSoxy/DDAB film was
washed off quickly, and the experiment could not finish successfully.
Table 3.2 The ratio of electron to nitromethane molecule

Mb/DDAB

Hm/DDAB

Total electrons
passed

Total nitromethane
molecules reduced

Electrons per
molecule

Trial 1

7.20 × 1018

1.54 × 1018

4.68

Trial 2

7.33 × 1018

1.65 × 1018

4.44

Trial 3

7.62 × 1018

1.80 × 1018

4.23

Trial 1

7.12 × 1018

1.58 × 1018

4.51

Trial 2

6.59 × 1018

1.41 × 1018

4.67

Trial 3

7.98 × 1018

1.81 × 1018

4.41

4.45 ±
0.22

4.53 ±
0.13

The results show that the final products of the electrocatalysis mediated by hemin or
hemoprotein are the same. Therefore, the reaction mechanisms for these catalysts are
likely the same as we proposed in last chapter with heme as the major player.
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3.4 Conclusion
iNOSoxy-mediated electroreduction of nitromethane shows highest catalytic ability
close to the bare hemin-facilitated one. Low Km of iNOSoxy indicates a high heme
binding affinity to a catalytically active form derived from the substrate. This is likely
facilitated by the thiolate fifth ligand of heme and flanking residues around heme binding
site. The scan rate dependency study shows that the protein shells of myoglobin and
iNOSoxy control the mass transfer to the active site. Furthermore, the pH dependency
study implies that the residues close to the heme binding site may mediate proton transfer
or act as proton donors to assist the catalytic transformations.
Comparing electroactivation of nitromethane catalyzed by two distinct hemoprotein
and bare hemin illustrates the effects caused by the protein shell and iron ligation as well
as the effects caused by residues around the heme site.
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CHAPTER IV
CATALYTIC ELECTROREDUCTION OF ALIPHATIC NITROALKANES
MEDIATED: A COMPARATIVE STUDY OF INOSOXY AND HEMIN AS
HEME-CATALYSTS

4.1 Introduction
Most nitroalkanes are toxic,1 and some are even found to be carcinogenic2-6 and
genotoxic7. Nitromethane is an example of nitroalkanes that are potent carcinogens.8 Also,
1-nitropropane has demonstrated mutagenic activity7,

9, 10

in cells though no link to

carcinogenicity has been established even with chronic exposure.9 Some of the secondary
nitroalkanes such as 2-nitrobutane and 3-nitropentane may cause significant incidence of
hepatocarcinoma with metastasis in the lungs, and have also been found to be more
carcinogenic than their corresponding primary nitroalkanes.11 2-nitropropane is another
well-known hepatocarcinogen,12-14 and its mutagenicity has been studied widely using
animal models.10, 15-18
The types of cancer caused by nitroalkanes are different for, but the key step in each
carcinogenic process always involves a biotransformation of the nitroalkane into a more
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reactive compound. One possible metabolic pathway could be anaerobic nitro-reduction
catalyzed by cytochrome P450 xenobiotic metabolizing enzymes through electron
transfer producing alkyl hydroxylamines as the final product. This is in agreement with
some research of the anaerobic metabolism of nitro compounds using biological
samples.19, 20
Previously we tested nitromethane anaerobic electroreduction mediated by myoglobin,
hemin, and iNOSoxy. Our results indicate that electro-activation of nitromethane can be
catalyzed by hemin or hemoproteins, and the catalytic function of the heme may reflect
the metabolic pathway of nitromethane activation by P450 metabolizing enzymes under
anaerobic conditions. Mass spectroscopy shows that the catalytic reduction of
nitromethane under these conditions reduces the nitro group to hydroxylamine, possibly
through our proposed pathway, Scheme 4.1. Hence, we propose that nitroalkanes with
different alkyl groups may also be catalytically reduced to hydroxylamines through a
similar catalytic mechanism.
CH3NO2

+ 2 e- + 2 H+

CH3N=O

- H2O

+ Heme(FeII)
O

CH3

N

Heme(FeII)

+ 2 e- + 2 H+
- Heme(FeII)

CH3NHOH

Scheme 4.1 Proposed heme-catalyzed electroreduction of nitromethane

The size of the alkyl group might affect the mass transport in diffusion-controlled
electrochemical techniques such as cyclic voltammetry. The different alkyl groups in
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nitroalkanes may also affect the chemical properties of their nitro groups, therefore
exhibiting effects on catalytic reduction. Because of these potential changes in chemical
properties, we examined four different substrates in this study, nitromethane, nitroethane,
1-nitropropane, and 2-nitropropane, Scheme 4.2.

H
H

C

O
N+

H

O–

H

nitromethane

H
C

O
N+

C
H
H
H

O–

nitroethane

H

O
N+

H
C

H O
N+ –
C
O

C
O–
C
H
C
H
H
H

H

1-nitropropane

2-nitropropane

H

H

H
H C H
H

Scheme 4.2 Structures of the nitroalkanes used in the study
In this part, the various nitroalkanes are tested on Hm/DDAB/PG and
iNOSoxy/DDAB/PG electrodes, and catalytic currents from cyclic voltammetry are used
as the expressions of the catalysis. Mass spectrometry is used to identify the products of
heme-mediated electroreduction of these 4 nitroalkanes. The catalytic efficiencies of
different substrates are contrasted and effects of factors such as substrate concentration,
scan rate of cyclic voltammetry, and pH, are discussed.
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4.2 Experimental design
4.2.1

Material

Hemin, Nitromethane, Nitroethane, 1-Nitropropane, and 2-nitropropane are
purchased from Sigma and used without further process. Didodecyldimethyl-ammonium
bromide (DDAB) is from Acros Organics. Oxygenase domain of inducible nitric oxide
synthase (iNOSoxy) is expressed and purified in our laboratory using the procedure
described in chapter 3.
Nitrogen, compressed from PRAXAIR. Deionized water is obtained from a Barnstead
Nanopure system with a resistivity greater than 18 MΩ · cm. Pyrolytic graphite
(Advanced Ceramics) is the material for the working electrodes. Homemade working
electrodes are prepared as in reference.21
4.2.2

Methods

The hemin and iNOSoxy modification of electrodes have been described in chapter 3.
Electrochemical techniques employed and the apparatus are the same as chapter 2.
Bulk electrolysis is performed at -1.0 V vs. Ag/AgCl under constant stirring for 1
hour. A large surface PG electrode modified with Hm/DDAB or iNOSoxy/DDAB is used
as a working electrode. The starting concentration of nitroalkane is 1.96 mM in 5 mL of
solution, and the concentration of nitroalkane after the electrolysis is estimated using an
electrochemical method. The consumption of nitroalkane is derived from the difference
between the initial amount and final amount. The total charge passed during the
electrolysis is recorded. The total number of electrons per nitroalkane molecule can
therefore be calculated.
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A mass spectrometric method is employed to identify the product after the bulk
electrolysis. The solution after electrolysis is infused into an electro spray ionization
triple quadrupole (ESI-QQQ) mass spectrometer (Micromass Quattro II). The product is
identified by the m/z ratio on the mass spectrum.
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4.3 Results and discussion
4.3.1

Direct electroreduction of nitroalkanes on a DDAB/PG and catalytic

electroreduction

of

nitroalkanes

mediated

by

Hm/DDAB/PG

and

iNOSoxy/DDAB/PG
Figure 4.1 shows the electroreduction of nitroalkanes on DDAB/PG electrodes. Since
there is no catalyst involved, we label these processes as direct reductions or nonmediated reductions. The reduction current response for the various nitroalkanes are in
the order of nitromethane > nitroethane > 1-nitropropane > 2- nitropropane, and the
reductive potentials from positive to negative are 1-nitropropane (-1.133 V),
nitromethane (-1.195 V), nitroethane (-1.217 V), and 2- nitropropane (-1.221 V). The
hemin-mediated catalytic reductions (Figure 4.2) show that the current intensities are in
the same order of that of direct reduction, and the potential from positive to negative
follows the order 1-nitropropane (-0.972 V), 2-nitropropane (-0.979 V), nitromethane (1.001 V), and nitroethane (-1.042 V). The reduction currents of iNOSoxy-mediated
reactions (Figure 4.3) follow the same order as the direct reductions, and the reduction
potentials also show the same order as for the direct reductions but at much positive
potentials: 1-nitropropane (-1.024 V), nitromethane (-1.049 V), nitroethane (-1.056 V),
and 2-nitropropane (-1.058 V). In addition, the potentials of iNOSoxy-mediated
electroreductions are very close to each other.
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Potential V

Figure 4.1 Cyclic Voltammograms of DDAB/PG electrode in pH 5.5 buffer at 150 mV/s
in the presence of nitroalkanes. (a) 0.2 mM nitromethane, (b) 0.2 mM nitroethane, (c) 0.2
mM 1-nitropropane, and (d) 0.2 mM 2-nitropropane.
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Figure 4.2 Cyclic Voltammograms of Hm/DDAB/PG electrode in pH 5.5 buffer at 150
mV/s in the presence of nitroalkanes. (a) 0.2 mM nitromethane, (b) 0.2 mM nitroethane,
(c) 0.2 mM 1-nitropropane, and (d) 0.2 mM 2-nitropropane.
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Figure 4.3 Cyclic Voltammograms of iNOSoxy/DDAB/PG electrode in pH 5.5 buffer at
150 mV/s in the presence of nitroalkanes. (a) 0.2 mM nitromethane, (b) 0.2 mM
nitroethane, (c) 0.2 mM 1-nitropropane, and (d) 0.2 mM 2-nitropropane.
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The current intensities of direct electroreductions on the DDAB/PG and the hemefacilitated electroreduction (Figure 4.2 and Figure 4.3) exhibit the same trend in that
smaller nitroalkanes have higher catalytic currents. An obvious reason is that the
diffusion that controls mass transport plays to the advantage of small molecules, Table
4.1. To see the effect of molecular size of the nitroalkane substrate, we examined and
compared the effect of scan rate of catalytic reduction of the various nitroalkanes.
Table 4.1 Hydrodynamic radiuses of the alkyl groups22

r (nm)

methyl

ethyl

propyl

isopropyl

0.20

0.225

0.25

0.30

For heme-mediated reduction of the four nitroalkane substrates, the reduction peaks
in the voltammograms all shift to positive potentials compared to the direct reductions.
The same is true for hemin-mediated catalysis but the current intensities are relatively
larger. The shift of the reductions to positive potentials and the increase of reaction rate
are typical features for electrocatalytic process. Therefore, hemin and iNOSoxy are
efficient electrocatalysis for the electroreductions of the 4 nitroalkane substrates.
The direct reduction potentials follow the order of nitromethane, nitroethane, and 2nitropropane. This trend may be explained by the inductive and hyperconjugative effects
of alkyl groups.23 Alkyl groups are considered as electron-donating to the nitro group,
and the inductive effect (+I) follows the order -CH3 < -CH2CH2CH3 < -CH2CH3 < CH(CH3)2. The effect increases the negative charge on the nitro group therefore make the
reduction more difficult. However, 1-nitropropane is unique among the 4 substrates. It
shows the most positive potential in both direct electroreduction and heme-mediated ones.
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A possible reason is that the reduction of 1-nitropropane, with the smallest dielectric
constant among the 4 nitroalkanes, is favorable on our electrodes modified with
hydrophobic DDAB films. Stabilized intermediates derived from this nitroalkane relative
to the other 3 substrates may also play a role in these reductions at positive potentials.
One may notice that the hemin-mediated 2-nitropropane displays the largest shift of
reduction potential from –1.221 V to –0.979 V among all the nitroalkane substrates. The
hemin catalyst in the reaction lowers the activation energy of 2-nitropropane reduction
more than those of the other 3 substrates. It is possible that in the heme-mediated
reduction, 2-nitropropane forms the hemin ferrous 2-nitrosopropane complex that can be
reduced at low potential, and the mediation by hemin may also compensate for the
inductive effects that makes 2-nitropropane hard to reduce.
4.3.2 Identification of the products of the hemin-mediated electroreduction of
nitroalkanes
It is critical to know the products of the catalytic electroreduction and number of
electrons consumed per substrate molecule so that the mechanism of the catalysis can be
derived. To find out the ratio of electron to nitroalkane molecules, we perform bulk
electrolysis using each of the 4 nitroalkane substrates. From the total electrons passed
and total amount of nitroalkane consumed, one can calculate the electrons per molecule.
The results of this work are listed in Table 4.2. The products of catalytic electroreduction
of nitroalkanes are identified by mass spectrometry (Figure 4.4) using the solution after
bulk electrolysis (Table 4.3).
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Table 4.2 The ratio of electron to nitroalkane molecule
Total electrons

Total molecules

Electrons per

passed

reduced

molecule

nitromethane

8.45 × 1018

1.93 × 1018

4.38

nitroethane

7.15 × 1018

1.69 × 1018

4.23

1-nitropropane

7.54 × 1018

1.81 × 1018

4.17

2-nitropropane

7.07 × 1018

1.63 × 1018

4.34

Table 4.3 The products of catalytic electroreduction of nitroalkanes
The products of catalytic electroreduction
nitromethane

methyl hydroxylamine (CH3-NHOH)

nitroethane

ethyl hydroxylamine (C2H5-NHOH)

1-nitropropane

propyl hydroxylamine (C3H7-NHOH)

2-nitropropane

isopropyl hydroxylamine ((CH3)2C-NHOH)
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Figure 4.4A Mass spectra of 2 mM nitromethane in the buffer solution (a) before and (b)
after the bulk electrolysis.
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Figure 4.4B Mass spectra of 2 mM nitroethane in the buffer solution (a) before and (b)
after the bulk electrolysis.
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Figure 4.4C Mass spectra of 2 mM 1-nitropropane in the buffer solution (a) before and
(b) after the bulk electrolysis.
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Figure 4.4D Mass spectra of 2 mM 2-nitropropane in the buffer solution (a) before and
(b) after the bulk electrolysis.

130

Since the mass spectrometric results show that the reduction products of nitroalkanes
are exclusively the corresponding alkyl hydroxylamine, and the ratio of electrons to
nitroalkane molecules is close to 4 for each substrate, the possible mechanism of the
catalysis may be similar to Scheme 4.1. We can therefore describe the electroreductions
by the following generalized scheme (Scheme 4.3).

RNO2

+ 2 e- + 2 H+

RN=O

- H2O

+ Heme(FeII)
O

R

+ 2 e- + 2 H+

N

- Heme(FeII)

Heme(FeII)

RNHOH

Scheme 4.3 Heme-catalyzed electroreduction of nitroalkanes

4.3.3 The effect of substrate concentration
The catalytic current increases as the concentration of substrate increases, Figure 4.5.
One can see that the first redox couple FeIII/FeII, which is caused by the surface confined
hemin is not affected by the addition of nitroalkanes. Therefore, we can use the reductive
wave of I0 as an indication of the amount of hemin in the film. To eliminate the effect
that is caused by the slight difference among electrodes, we use the ratio of Icat / I0 and
referred it as catalytic efficiency. This way we can compare the catalysis of different
nitroalkanes with different electrodes. From the plot of catalytic efficiencies as functions
of substrate concentration, Figure 4.6 and Figure 4.7, one can see that the catalytic
efficiencies increase steadily at low concentrations and tend to reach maximum at high
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concentrations. This catalysis saturation behavior fits Michaelis-Menten enzyme kinetics,
Equation 4.1.

V =

Vmax × [ S ]
K m + [S ]

(Michaelis-Menten Equation)

(4.1)

Since we use the normalized catalytic current, Icat / I0, as the measurement of the
velocity of the reaction, Figure 4.6 and 4.7 can be treated as Michaelis-Menten plot. To
obtain the kinetic parameters of the catalyst, we perform the non-linear regression using
Michaelis-Menten equation and we can estimate the Km values for each substrate and
each catalyst system, Table 4.4.
Table 4.4 Km values of hemin and iNOSoxy for different nitroalkane substrates from the
non-linear regression of the Mechaelis-Menten plots

Hemin

iNOSoxy

nitromethane

nitroethane

1-nitropropane

2-nitropropane

Km (mM)

4.4 ±0.50

4.04 ±0.25

6.03 ±0.39

6.11 ±0.69

kcat (s-1)

68.3 ± 6.3

55.6 ± 4.8

45.8 ± 3.7

39.5 ± 4.1

kcat/Km
(s-1·mM-1)

15.6

13.8

7.6

6.5

Km (mM)

1.81±0.17

2.14±0.31

2.06±0.12

2.76±0.29

kcat (s-1)

28.1±2.2

26.3±1.9

23.1±1.7

20.7±1.6

kcat/Km
(s-1·mM-1)

16.5

12.3

11.2

7.5
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Figure 4.5 Cyclic voltammograms (a) 0 mM, (b) 0.3 mM, (c) 0.8 mM, (d) 1.3 mM, and
(e) 2.0 mM of nitromethane electroreduction mediated by Hm/DDAB/PG in pH 5.5
buffer at 0.15 V/s.
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Figure 4.6 Catalytic efficiency as a function of nitroalkane concentration for
Hm/DDAB/PG electrode. (a) nitromethane (b) nitroethane (c) 1-nitropropane (d) 2nitropropane
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Figure 4.7 Catalytic efficiency as a function of nitroalkane concentration for
iNOSoxy/DDAB/PG electrode. (a) nitromethane (b) nitroethane (c) 1-nitropropane (d) 2nitropropane
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Comparing the Km of nitroalkane substrates in hemin-catalyzed reduction,
nitromethane and nitroethane have similar smaller values, whereas 1-nitropropane and 2nitropropane both have relatively larger values. Steric effects may contribute to this trend.
Therefore, the larger Km can be rationalized by the steric hindrance caused by the larger
alkyl groups in the substrate-catalyst interaction process. This effect may cause a
difference between smaller and larger nitroalkanes or between straight versus branched
nitroalkanes because of their different geometric arrangements. This observation is
consistent with previous reports that indicate the formation rate of the heme ferrous
nitrosoalkane in solution is slower for larger nitroalkanes such as 2-nitropropane.24
The other Michaelis-Menten parameter kcat can be obtained by non-linear regression
of the Michaelis-Menten plot using the electrochemical format of Michaelis-Menten
equation, as described in Chapter 2. The kcat and the kcat/Km of each substrate indicate that
hemin can catalyzed the electroreduction of smaller nitroalkane more efficiently than
larger ones, and linear nitroalkane 1-nitropropane has higher turnover rate than the
branched one.
In both case of hemin and iNOSoxy-mediated activation of different nitroalkanes, the
catalytic efficiency follows the order: nitromethane > nitroethane > 1-nitropropane > 2nitropropane, Figure 4.6 and 4.7, Our results suggest that the smaller the nitroalkane, the
higher the catalytic efficiency. In addition, branched nitroalkanes show slightly lower
rates of catalysis than their linear counterparts.
The Km constants of nitroalkanes electroreduction for hemin as a catalyst are
significantly larger than that for iNOSoxy. The proximal thiolate ligand of the iNOSoxy
heme group help stabilize the trans-ligand, and the flanking residues around the binding
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site also facilitate the binding of intermediates during turnover. These conditions are not
met for bare hemin and thus large Km value results.

4.3.4 The effect of scan rate
Scan rate of cyclic voltammetry defines the timescale within which the catalytic
reaction is observed as well as substrate and product transports by diffusion. Increase of
scan rate shortens the timescale and the catalysis is monitored very early in the process
(less catalytic turnovers). As we seen in Figure 4.8, Ica /I0 decreases with logarithm of
scan rate. Catalytic efficiencies of hemin-mediated electroreduction as a function of scan
rate (Figure 4.8) shows the same trend for all the substrates, and within the same range of
scan rate, the catalytic efficiencies of the 4 substrates follows the order nitromethane >
nitroethane > 1-nitropropane > 2-nitropropane. Therefore, the size of the substrate
molecule plays an important role in the catalysis. More of this will be discussed when we
present our results of digital simulation of the catalytic process.
The catalytic efficiencies of iNOSoxy-mediated reduction of nitroalkane substrates
show the expected decreasing trend with increasing scan rate, Figure 4.9. At low scan
rate region (<1 V/s), the catalytic efficiencies of iNOSoxy-mediated reductions decrease
faster than the efficiencies of the same reaction catalyzed by hemin. From scan rate 1V/s
to 20V/s, the catalytic efficiency only exhibits only a slight decrease for all 4 substrates.
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Figure 4.8 Catalytic efficiency as a logarithmic function of scan rate for Hm/DDAB/PG
in pH5.5 buffer in the presence of 0.2 mM nitromethane. (a) nitromethane (b) nitroethane
(c) 1-nitropropane (d) 2-nitropropane
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Figure 4.9 Catalytic efficiency as a logarithmic function of scan rate for
iNOSoxy/DDAB/PG in pH5.5 buffer in the presence of 0.2 mM nitromethane. (a)
nitromethane (b) nitroethane (c) 1-nitropropane (d) 2-nitropropane
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4.3.5 The effect of pH
The catalytic electroreduction of nitroalkane is a 4-electron 4-proton process. The
proton availability will obviously affect the efficiency of the catalysis. As seen in Figure
4.10 and Figure 4.11, catalytic efficiencies decrease with increasing pH. However, the
trend of decrease for each substrate is irregular and unique, pointing to other factors that
affect the catalytic reduction at different pHs other than proton availability.
Nitroalkanes are polar and slightly acidic in aqueous medium. Primary and secondary
nitroalkanes can dissociate into nitronate anions and protons, Equation 4.2. The aci-nitro
tautomerism of nitroalkane shows the equilibria of nitronic acid, R1R2C=NO2H (aci form),
nitroalkane, and the nitronate anion R1R2C=NO2- in neutral or basic medium, Equation
4.3.25

R1R2CH-NO2 + H2O

k1

R1R2C=NO2- + H3O+

(4.2)

k-1
R1R2C=NO2H

k2

R1R2C=NO2- + H+

k-1

R1R2CH-NO2

(4.3)

k1

k-2

Because of the intramolecular proton transfer, the nitro group can transform into
several other functional groups. These unique chemical properties may play a role in the
catalytic electroreduction of nitroalkanes. As shown in Nielsen’s work,25 pH is closely
related to the tautomerization (equation 2) of nitroalkanes. Since the nitronate anion of
nitroalkane is not electro reducible,25 the ionization of nitroalkane should have an effect
on the electroreduction. The ionization constant pKanitro (Ka= k1/k-1) and pKaAci (Ka= k2/k-2)
for different nitroalkanes reported by Nielsen25 are in Table 4.5.
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Table 4.5 Ionization constant of nitroalkanes and nitronic acids in water25
nitroalkane

pKanitro

pKaAci

nitromethane

10.21

3.25

nitroethane

8.5

4.4

1-nitropropane

8.98

4.6

2-nitropropane

7.68

5.1

Since the ionization is much weaker for the nitro form of nitroalkane than the aci
form, the catalytic efficiency in acidic and neutral media would not be affected too much
by the ionization of nitroalkanes. However, in basic media, nitroalkanes will transform to
nitronic acids and make the electroreduction process difficult. For hemin-mediated
reductions, Figure 4.10a shows nitromethane having the sharpest decrease from pH 9 to
pH 10.5, and the catalytic efficiency declining slopes (pH >9) follow the order
nitromethane > nitroethane > 1-nitropropane > 2-nitropropane. This order fits the pKaAci
values of the aci form nitroalkanes.
We also tested the iNOSoxy-mediated catalytic reduction in the pH range from 5.35
to 10.00. The trends of the catalytic electroreduction for all the nitroalkane substrates
were similar. Results show that while iNOSoxy-mediated catalytic reductions are
dependent on protons, the dependence is less pronounced compared to hemin-mediated
catalysis. The protein shell of iNOSoxy very likely plays a role in mediating proton
transfers, which could act as a local buffer counteracting the change in bulk pH.
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Figure 4.10 Catalytic efficiency as a function of pH for the nitroalkane electroreduction
on Hm/DDAB/PG electrodes. (1) 0.2 mM nitromethane, (2) 0.2 mM nitroethane, (3) 0.2
mM 1-nitropropane, and (4) 0.2 mM 2-nitropropane.
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Figure 4.11 Catalytic efficiency as a function of pH for the nitroalkane electroreduction
on iNOSoxy/DDAB/PG electrodes. (1) 0.2 mM nitromethane, (2) 0.2 mM nitroethane, (3)
0.2 mM 1-nitropropane, and (4) 0.2 mM 2-nitropropane.
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4.3.6 Estimation of heterogeneous and homogeneous reaction rates
To further shed light on the mechanism and to assess the kinetics of catalytically
initiated steps, we decided to carry out digital simulation of the voltammetric response of
each substrate and catalytic system.
To test our working mechanism of heme-mediated nitroalkane electroreduction for
all four substrates, we used digital simulation to calculate voltammetric response and fit
our experimental data. We only show the results of hemin-mediated reduction.
The heme-mediated electroreduction of nitroalkanes involves multiple steps of
chemical and electrochemical reactions as proposed in our previous study, and can be
generalized as shown in Equation 4.4 to 4.7. The rate constant of each step can be
adjusted in the program until a satisfactory fit to experimental data is achieved. The
results from the simulations are tabulated in Table 4.6. The detailed simulation procedure
is showed in Chapter 2. The simulated voltammograms are shown in Figure 4.12.
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Figure 4.12 Digisim® simulation of cyclic voltammograms. (∎) simulated
voltammogram, (―) experimental voltammogram
(a) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM nitromethane at
(1) 200 mV/s, (2) 400 mV/s, and (3) 600 mV/s.
(b) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM nitroethane at (1)
200 mV/s, (2) 400 mV/s, and (3) 800 mV/s.
(c) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM 1-nitropropane at
(1) 200 mV/s, (2) 400 mV/s, and (3) 800 mV/s.
(d) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM 2-nitropropane at
(1) 200 mV/s, (2) 400 mV/s, and (3) 800 mV/s.
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Table

4.6

Digisim®

simulation

parameters

of

hemin-catalyzed

nitroalkane

electroreductions.

nitromethane

k1f (s-1· M-1)

k1b (s-1)

k2f (s-1)

kS1 (cm/s)

kS2 (cm/s)

2 × 104

20

70

3.8 × 10-7

0.01

4

25

55

3.3 × 10-7

0.01

nitroethane

2 × 10

1-nitropropane

1.5 × 104

44

46

2.5 × 10-7

0.01

2-nitropropane

1.5 × 104

50

40

2.1 × 10-7

0.01

For all the substrates, the direct electroreduction of nitroalkane is sluggish (kS1 is in
10-7 range), whereas the hemin-mediated electroreduction is fast (the rate constant kS2 is
0.01). It is common for a catalyzed reaction. The catalyst-substrate complex formation
rate k1f for smaller nitroalkanes (CH3NO2 and CH3CH2NO2) is faster and slower for the
larger ones. The catalyst-substrate complex dissociation rate k1b follows the order
nitromethane<nitroethane<1-nitropropane<2-nitropropane. The simulation results nicely
agreed with the arguments that in our previous discussion.
In addition, the results showed that the reaction rate of each step can fit perfectly to
the Michaelis-Menten parameters (Table 4.4) as we know that by definition, k2f is equal
to kcat and Km is equal to (k1b + k2f) / k1f. To show the relationship between MechaelisMenten parameters and reaction rate constants, we put the results from digital simulation
and the results from Mechaelis-Menten analysis side by side in Table 4.7.
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Table 4.7 The parameters derived from digital simulation and non-linear regression of
Mechaelis-Menten plots.
Mechaelis-Menten analysis

Digital simulation
k1f (s-1· M-1)

k1b (s-1)

k2f (s-1)

Km (mM)

kcat (s-1)

nitromethane

2 × 104

20

70

4.4 ±0.50

68.3 ± 6.3

nitroethane

2 × 104

25

55

4.04 ±0.25

55.6 ± 4.8

1-nitropropane

1.5 × 104

44

46

6.03 ±0.39

45.8 ± 3.7

2-nitropropane

1.5 × 104

50

40

6.11 ±0.69

39.5 ± 4.1

Digital simulation of heme-mediated electroreduction of nitroalkanes confirms our
generalized mechanism of electrocatalysis. In addition, the rate constants of elementary
steps of the electroreduction as derived from digital simulations over a range of scan rate
agree very well with the numbers found for kcat and Km derived from simple MechaelisMenten analysis.
Simulated catalytic efficiency is obtained by dividing the simulated catalytic current
(using a proposed mechanism scheme) by the simulated hemin(FeII) current without
substrate. The simulated catalytic efficiency as a function of scan rate result is shown in
Figure 4.13. The simulated curve fits our experimental data well as shown in Figure 4.13.
This great fit of simulated curve to experimental data over a range of scan rates is an
indication of the validity of the proposed mechanism as reported in the previous section.
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Figure 4.13 Simulated scan rate dependency curve with experimental data (a)
nitromethane (b) nitroethane (c) 1-nitropropane (d) 2-nitropropane
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4.4 Conclusion
Mass spectrometry shows that heme-mediated electroreductions of nitromethane,
nitroethane, 1-nitropropane and 2-nitropropane produce the corresponding alkyl
hydroxylamines as the final product. The intrinsic properties of aliphatic nitroalkanes
affect their electroreduction process. The potential of catalytic peak differences among
the various nitroalkanes seem to match inductive effect of alkyl groups connected to the
nitro group. The size and shape of the substrate have a clear effect on the turnover rate.
Smaller nitroalkanes exhibit higher turnover rates as compared to the larger ones. The Km
value of hemin catalyst for each nitroalkane substrate indicates the stability of the
catalyst-substrate intermediate complex, which is likely, a heme-nitrosoalkane complex;
smaller nitroalkanes such as nitromethane and nitroethane exhibit higher stability. The
study of pH catalysis dependency shows that the catalytic reduction is affected by the
intrinsic ionization of the nitronic acid. Digisim simulations of cyclic voltammograms not
only estimate the reaction rate of each elementary step of our proposed mechanism of the
electrocatalysis, but also reinforce and validate the parameters derived from non-linear
regression fitting of Michaelis-Menten plots.
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Appendix A

Cyclic Voltammetry
Cyclic voltammetry (CV) is a potentiodynamic electrochemical technique. In a
cyclic voltammetry experiment the working electrode potential is scanned linearly versus
time as shown in the potential waveform plot. When the scan reaches a set point of
potential, the potential scan is inverted. This inversion can be set multiple times during
one single experiment. The current passing through the working electrode is recorded
versus the potential applied to give the cyclic voltammogram. The waveform and
resulting voltammogram is shown in Figure A1.
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Figure A1 Waveform and resulting voltammogram of cyclic voltammetry (CV)
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Appendix B

Demonstration of fabricating PG working electrodes

Glass tubing
Copper wire

Conductive Epoxy
Non-conductive
epoxy

Graphite cylinder

Figure B Fabrication of the PG working electrode.
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Appendix C
DigiSim® simulation
DigiSim is a simulation software developed by BASi for cyclic voltammetry.
DigiSim can be used to simulate any electrochemical mechanism that can be expressed in
terms of single or multiple electron transfer reactions and first- and second-order
homogenous reactions. In addition, DigiSim can generate dynamic concentration profiles
and can fit simulated data to imported experimental data.1

Mechanism used to fit our cyclic voltammogram:
CH3NO2 + 2e = CH3NO
FeII + CH3NO = FeIICH3NO
FeIICH3NO + 2e = FeIICH3NHOH
FeIICH3NHOH = FeII + CH3NHOH
FeII + e = FeI

(1)
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